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De novo Expression of Parvalbumin in
Ependymal Cells in Response to Brain Injury
Promotes Ependymal Remodeling
and Wound Repair
Viktoria Szabolcsi and Marco R. Celio
The calcium-binding protein parvalbumin (PV) hallmarks subpopulations of interneurons in the murine brain. We serendipi-
tously observed the de novo expression of PV in ependymal cells of the lateral ventricle wall following in vivo lesioning and
brain slicing for the preparation of organotypic hippocampal slice cultures (OHSCs). In OHSCs, de novo PV-expression begins
shortly after the onset of culturing, and the number of ependymal cells implicated in this process increases with time. PV-
immunopositive ependymal cells aggregate and form compact cell clusters, which are characterized by lumen-formation and
beating cilia. Scratches inflicted on such clusters with a sharp knife are rapidly closed. Exposure of OHSCs to NF-RB-
inhibitors and to antioxidants reduces PV-expression in ependymal cells, thereby implicating injury-induced inflammation in
this process. Indeed, in vivo stab injury enhances PV-expression in ependymal cells adjacent to the lesion, whereas neuramini-
dase denudation is without effect. PV-knock-out mice manifest an impaired wound-healing response to in vivo injury, and a
reduced scratch-wound reparation capacity in OHSCs. Whole-transcriptome analysis of ependymal-cell clusters in OHSCs
revealed down-regulation of genes involved in cytoskeletal rearrangement, cell motility and cell adhesion in PV-knock out
mice as compared with wild-type mice. Our data indicate that the injury-triggered up-regulation of PV-expression is mediated
by inflammatory cytokines, and promotes the motility and adhesion of ependymal cells, thereby contributing to leakage clo-
sure by the re-establishment of a continuous ependymal layer.
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Introduction
A monolayer of multiciliated, cuboidal ependymal cellslines the brain ventricles (Bruni, 1998; Del Bigio, 2010).
The ependymal cell layer of the lateral ventricles is in inti-
mate spatial contact with the subventricular zone (SVZ),
which harbors both neural stem cells (NSCs) giving rise to
neuroblasts throughout life and differentiated niche cells
(Zhao et al., 2008). This neurogenic niche has a finely-
regulated microenvironment created by the two main niche
cells, ependymal cells and astrocytes (Mirzadeh et al., 2008),
which facilitates the maintenance of neurogenesis (Kazanis
et al., 2008; Kokovay et al., 2008). It is characterized by a
stringent spatial organization in which the ependymal cells
form a pinwheel-like structure around monociliated NSCs
(Mirzadeh et al., 2008). Ependymal cells also secrete substan-
ces that influence the proliferation of stem cells, such as the
pigment epithelium-derived factor (PEDF) (Ramirez-Castil-
lejo et al., 2006), noggin (Lim et al., 2000) and low-density
lipoprotein-related protein 2 (LRP2) (Gajera et al., 2010).
Ependymal cells could promote various functions in the
NSC-niche, including detoxification and scavenging of sub-
stances in the cerebrospinal fluid (Del Bigio, 2010), modula-
tion of ion transport and regulation of neuroblast migration
(Sawamoto et al., 2006). Disruption of the ependymal-niche
assembly by a removal of the lateral-membrane-
adaptor-protein ankyrin-3 leads to a disorganization of the
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SVZ-architecture and to a massive reduction in neurogenesis
(Paez-Gonzalez et al., 2011), highlighting the impact of ependy-
mal cells in the maintenance of stem cell proliferation and neuro-
blast migration. Niche ependymal cells and astrocytes were
recently found to maintain a high level of plasticity and to be
interconvertible by disrupting Notch- and EphB-signaling or
upon niche remodeling following injury (Nomura et al., 2010).
Ependymal cells express epidermal growth factor receptor
(EGFR) and platelet-derived growth factor receptor alpha
(PDGFRa) (Danilov et al., 2009), acquire a reactive phenotype
post stroke (Young et al., 2013) and during aging (Capilla-Gonza-
lez et al., 2014), and display similar functional properties to those
shown in astrocytes, such as the presence of gap junction cou-
pling, KIR channels, and glutamate transporters (Liu et al., 2006).
Nevertheless, the ependymal layer, unlike other epithelial
linings, is nonregenerative; ependymal cells do not proliferate in
the adult brain (Spassky et al., 2005). During the process of
aging or following neuraminidase-induced denudation of the
ependymal layer, a limited repair response is sustained by an
active SVZ-stem-cell niche in mice (Luo et al., 2008). In the
aging brain, stretching of the ependymal cells (Shook et al.,
2013) and the acquirement of a flattened and elongated mor-
phology (Capilla-Gonzalez et al., 2014) has also been observed,
indicating that they retain limited capacity for local remodeling.
One traditional ependymal-cell marker is S100b, a
calcium-binding protein (CaBP) of the EF-hand family that
also labels astrocytes (Cocchia, 1981). S100b exerts both intra-
and extracellular functions; intracellularly, S100b is a Ca21-
sensor, acts as a stimulator of cell proliferation and migration,
and might be implicated in the activation of astrocytes in the
course of brain damage (Donato et al., 2009). Another mem-
ber of this family, parvalbumin (PV), is classically expressed in
discrete populations of neurons in the brain, as well as in mus-
cle fibers (Celio, 1990; Celio and Heizmann, 1981). No signif-
icant intrinsic PV-expression has been detected in either
developing or adult glial cells, with only sporadic PV-
expression reported in isolated ependymal cells of the lateral
ventricle (Celio, 1990; Solbach and Celio, 1991) (see also
www.brain-map.org for negative in situ hybridization results).
We report that mechanical brain injury involving the lat-
eral ventricle wall triggers the de novo expression of PV in a
large subpopulation of ependymal cells close to the site of injury
in vivo and in organotypic cultures in vitro. Our data suggest
that the de novo expression of PV in ependymal cells promotes
their motility and adhesion, thereby facilitating wound repair
and preventing the leakage of cerebrospinal fluid.
Materials and Methods
Mice
C57BL/6 (Janvier, Lyon, France), Parvalbumin-Cre/loxP-DsRed-
loxP-EGFP (hereafter: PV-Cre/EGFP), PV-KO, PV-KO/EGFP and
Foxj1/EGFP mice (Jackson Laboratory, Bar Harbor, ME) were used
to prepare organotypic hippocampal slice cultures (Table 1). Mice
expressing Cre under the parvalbumin promoter were crossed with
an IRG (insulator/red/green) transgenic, double-fluorescent, Cre-
reporter strain [B6;C3-Tg(CAG-DsRed,-EGFP)5Gae/J; Jackson Lab-
oratory, Sacramento, CA], which has a widespread expression of a
loxP-flanked red fluorescent protein variant (DsRed-Express) prior
to Cre recombinase exposure, and enhanced green fluorescent pro-
tein (EGFP) following cre-mediated recombination. When bred to
mice that express Cre under the parvalbumin promoter, the resulting
offspring have the DsRed-Express cassette deleted in the
parvalbumin-expressing cells, allowing expression of the EGFP cas-
sette located just downstream. In a second set of experiment, PV-
KO/EGFP mice were generated by crossing a PV/EGFP strain
(B6.Tg(Pvalb-EGFP)1Hmon) to a PV-KO strain (B6.Pvalbtm1Swal
XB6Tg(Pvalb-EGFP)1Hmon). In a third set of experiments, a
Foxj1/EGFP mice strain [(B6;C3-Tg(FOXJ1-EGFP)85Leo/J, Jackson
Laboratory, Sacramento, CA, USA] expressing EGFP under the con-
trol of the human forkhead box J1 (Foxj1) gene promoter (Ostrow-
ski et al., 2003) was used for organotypic cultures. All animal
experiments were performed according to institutional guidelines
and with the permission of the Swiss federal and cantonal committee
on animal experimentation (Permission Nr: 22170 2012_26_FR and
21260 2010_26_FR).
Organotypic Hippocampal Slice Cultures (OHSCs)
Organotypic hippocampal slice cultures (OHSCs) were generated
from 7 postnatal-day-old C57BL/6, PV-Cre/EGFP, PV-KO, PV-KO/
EGFP, and Foxj1/EGFP mice, using the interface method previously
described (G€ahwiler et al., 2001; Stoppini et al., 1991). After decapi-
tation and excision of the brain, hippocampi were isolated manually
under a stereomicroscope. Once isolated, the hippocampus was
sliced to 400-mm-thick cross-sections with a McIlwain Tissue Chop-
per (Mickle Laboratory Engineering, Goose Green, UK). The hippo-
campal slices were transferred onto sterile cell culture inserts of 0.4-
mm pore size and 30-mm diameter (MillicellVR , Millipore, Zug, Swit-
zerland). In some experiments, slice cultures were also prepared—as
described above—from the region of the brain containing the lateral
wall of the lateral ventricle, following the isolation and removal of
the hippocampi. Slice culture inserts were placed into standard six-
well plates (Fisher Scientific, Wohlen, Switzerland) in an automatic
CO2 incubator (Fisher Scientific, Wohlen, Switzerland) at 37
C in
5% CO2 in serum-based medium (50% DMEM, 25% HBSS, 25%
horse serum, 6.5 g L21 glucose, fungizone, penicillin/streptomycin)
or transferred after 2 days in a serum-free medium (Neurobasal-A
medium with B27-supplement, 5 mM Glucose, 2.5 mM L-gluta-
mine, Fungizone, penicillin/streptomycin). All cell culture media,
reagents and supplements were from GIBCO (Life Technologies,
LuBioScience, Lucerne, Switzerland). Culture medium was replaced
every 2–3 days in a laminar flow. In some experiments, slice cultures
were treated with different compounds added to the dissection- and
culturing medium to block the effect of certain cytokines and growth
factors, e.g. nuclear factor kappa B (NF-RB) activation inhibitors
pyrrolidine dithiocarbamate (PDTC, 500 mM, Sigma–Aldrich,
Buchs, Switzerland) and 6-Amino-4-(4-phenoxyphenylethylamino)
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quinazoline (Act, 100 nM, Millipore, Zug, Switzerland); antioxidant
N-acetyl-cysteine (NAC, 100–500 mM, Sigma–Aldrich, Buchs, Swit-
zerland), gamma-glutamylcysteine synthetase-inhibitor buthionine
sulfoximine (BSO, 100–500 mM, Sigma–Aldrich, Buchs, Switzer-
land) and EGFR inhibitor cyclopropanecarboxylic acid-
dianilinopyrimidine (50 lM, Millipore, Zug, Switzerland). Slice cul-
tures were maintainted for 1–70 days in vitro (DIV1-DIV70), then
fixed for 3 h in 4% paraformaldehyde (PFA, Sigma-Aldrich, Buchs,
Switzerland) solution in 0.1M Phosphate Buffer (pH 7.4) at room
temperature, and processed for further experiments.
Mechanical Lesion of the Ependymal Zone in OHSC
OHSCs prepared from C57BL/6, PV-KO, PV-Cre/EGFP, and PV-
KO-EGFP mice (n 5 3 for each mouse line, number of slices varied
from six to nine slices per mouse; i.e. 18 scratch-wounds per mouse
line were evaluated) were subjected to a manually performed mechani-
cal lesion at the region of the ependymal zone at DIV7. The lesion
was implemented under a stereomicroscope with a sharp microdissec-
tor of 100-mm tip-size. Lesioned OHSCs were then placed into a
Leica DMI6000 time-lapse fluorescent microscope (Leica, Germany)
equipped with an environmental chamber and images were taken
every 15 min for a total duration of 41 h. To assess the scratch closure
time, the image series obtained in the bright field channel were used
to define and measure various parameters, such as the scratch-wound
area (in mm2) and the wound edge distances (in mm) along three par-
allel lines drawn in the area of the scratch, perpendicular to the angle
of the lesion. These parameters were measured over the whole dura-
tion of the time-lapse recording at an interval of every 3 h in each slice
subjected to a scratch. The obtained values were normalized to the ini-
tial scratch wound area and wound edge distances measured at the
“zero” time-point (the first image of the time-lapse recording after the
scratch) and are presented as percentages of the initial parameters. In
addition to the above mentioned parameters, the motion of individual
cells expressing EGFP (in mice of PV-Cre/EGFP and PV-KO-EGFP
slices) around the scratch were also measured as the distance (in mm)
between their initial position at the beginning of the time-lapse
recording and their position 24 h later. As control, the motion of
EGFP-expressing cells in unlesioned slices was measured.
TABLE 1: Transgenic Mice Used in the Study
Transgenic mice
name in the study
Systematic strain name Reference
PV-Cre/EGFP B6;129P2-Pvalbtm1(cre)Arbr/J X
B6;C3-Tg(CAG-DsRed,-EGFP)5Gae/J
Hippenmeyer S; Vrieseling E; Sigrist M; Portmann T;
Laengle C; Ladle DR; Arber S. 2005. A developmental
switch in the response of DRG neurons to ETS
transcription factor signaling. PLoS Biol 3(5):e159.
[PubMed: 15836427] [MGI Ref ID J:100886]
De Gasperi R; Rocher AB; Sosa MA; Wearne SL;
Perez GM; Friedrich VL Jr; Hof PR; Elder GA. 2008.
The IRG mouse: a two-color fluorescent reporter for
assessing Cre-mediated recombination and imaging
complex cellular relationships in situ.
Genesis 46(6):308-17. [PubMed: 18543298]
[MGI Ref ID J:137251]
PV-KO B6.Pvalbtm1Swal Schwaller, J. Dick, G. Dhoot, S. Carroll, G. Vrbova,
P. Nicotera, D. Pette, A. Wyss, H. Bluethmann,
W. Hunziker, M.R. Celio, Prolonged contraction-relaxation
cycle of fast-twitch muscles in parvalbumin knockout mice,
Am. J. Physiol. Cell Physiol. 276 (1999) C395 - C403
PV-KO/EGFP B6.Pvalbtm1SwalXB6Tg
(Pvalb-EGFP)1Hmon
Schwaller B. The use of transgenic mouse models to reveal
the functions of Ca21 buffer proteins in excitable cells.
Biochim Biophys Acta. 2012 Aug;1820(8):1294-303.
doi: 10.1016/j.bbagen.2011.11.008. Epub 2011 Nov 27.
Review. PubMed PMID: 22138448
Foxj1/EGFP (B6;C3-Tg(FOXJ1-EGFP)85Leo/J Ostrowski LE; Hutchins JR; Zakel K; O’Neal WK. 2003.
Targeting expression of a transgene to the airway surface
epithelium using a ciliated cell-specific promoter.
Mol Ther 8(4):637-45. [PubMed: 14529837]
[MGI Ref ID J:101822]
List of the transgenic mice used in the study, including the abbreviated form used throughout the manuscript, the systemic name of the
strains and the relating references.
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Cell Death Assays
OHSCs prepared from 7-day-old C57BL/6 and PV-KO (n 5 5
each) mice were subjected to an evaluation of cell death by assessing
propidium iodide (PI) uptake combined with measurement of lactate
dehydrogenase (LDH) activity in the culture medium. PI (Clontech,
Mountain View, CA) was added to the culture medium at a concen-
tration of 0.5 mg mL21 on DIV6. At DIV7, multiple OHSCs from
C57BL/6 and PV-KO (n 5 3 each) mice were subjected to a
mechanical lesion at the region of the ependymal zone as described
above, while control OHSCs from C57BL/6 and PV-KO (n 5 2
each) mice remained unlesioned. PI-stained cell nuclei in the epen-
dymal regions of all OHSCs of each animal were imaged using an
inverted fluorescent microscope (Leica DMI6000) at six different
time-points (1 h prior to scratching, 1, 8, 24, 48, and 72 h post-
scratching). Lactate dehydrogenase (LDH) release to the culture
medium was measured in culture wells containing OHSCs from
C57BL/6 and PV-KO (n 5 3 each) subjected to mechanical lesion
in the ependymal zone at DIV7, and OHSCs from control, unle-
sioned mice (C57BL/6 and PV-KO, n 5 2 each). For each animal,
two insert membranes—each holding 10 OHSCs—were cultured
and 20 mL of the culture media was obtained from each of the cul-
ture wells at six different time-points (1 h prior to scratching, 1, 8,
24, 48, 72 h post-scratching). The culture media samples were sub-
jected in technical duplicates to a quantitation of LDH activity using
the lactate dehydrogenase activity assay kit (Sigma–Aldrich, Buchs,
Switzerland) following the manufacturer’s instructions. In brief,
LDH reduces NAD1 to NADH, which is detected by a colorimet-
ric assay (kmax 5 450 nm). Culture media samples were incubated
at 37C in 96-well plates and absorbance at 450 nm was measured
every 5 min by a spectrophotometric multiwell plate reader (Victor
X3 by Perkin Elmer, Waltham, MA), followed by calculation of the
LDH activity based on the amount of NADH generated. Fresh cul-
ture media was used as negative control.
Whole-mount Immunohistochemistry
Whole-mount immunohistochemistry was performed with well char-
acterized antibodies to PV (1:1,000, polyclonal PV-28, monoclonal
PV-235, goat PV-214; Swant, Marly, Switzerland), S100b (1:1,000,
Swant, Marly, Switzerland), CD133/Prominin-1 (1:500, eBioscience,
Vienna, Austria), Doublecortin (1:100, Santa Cruz Biotechnology,
Heidelberg, Germany), Ki67 (1:500, NeoMarkers/Fisher Scientific,
Wohlen, Switzerland), GFAP (polyclonal 1:650, Dako Schweiz AG,
Baar, Switzerland and monoclonal 1:1,000, Novus Biologicals, Cam-
bridge, UK), Nestin (1:500, Millipore, Zug, Switzerland), BrdU
(1:200, Abcam, Cambridge, UK) and GFP (1:3,000; polyclonal and
monoclonal from Life Technologies, Milan Analytica, Rheinfelden,
Switzerland). Primary antibodies were diluted in 0.1M TBS pH 7.3
with 0.1% Triton X-100 and 10% bovine serum added and applied
overnight at 4C. After thorough washing, primary antibody staining
was revealed using species-specific fluorophore-conjugated secondary
antibodies (Cy5 from Jackson Immuno Research/Milan Analytica,
Rheinfelden, Switzerland; Alexa 488 and Alexa 568 from Life Tech-
nologies, LuBioScience, Lucerne, Switzerland). Antibodies against
Ki67 and the goat-antiserum PV-214 were detected with biotinylated
secondary antibodies (Jackson Jackson Immuno Research/Milan Ana-
lytica, Rheinfelden, Switzerland) and revealed using Cy5 conjugated
Streptavidin (Jackson Immuno Research/Milan Analytica, Rheinfel-
den, Switzerland).
Transmission Electron Microscopy (TEM)
OHSCs were prepared from 7 postnatal-day-old wild-type C57BL/6,
PV-Cre/EGFP and PV-KO/EGFP mice, and maintained in culture
for 7, respectively 31 days. OHSCs were fixed with a solution of 4%
PFA. Fixed whole-mount slice cultures were exposed to anti-PV-28
(rabbit, Swant, 1:2,000), respectively anti-GFP antibodies (mouse,
Life Technologies, 1:3,000) for 3 days at 4C, followed by the
avidin-biotin-preoxidase technique. The specimens were post-fixed in
a solution containing 2.5% glutaraldehyde in 0.1 M Na-cacodylate-
HCl buffer (pH 7.4) at room temperature for 2 h and thoroughly
rinsed with 0.1 M Na-cacodylate-HCl buffer. The specimens were
post-fixed with 1% OsO4 and dehydrated through graded ethanol
concentrations. After embedding in epon, regions containing
ependymal-cell clusters were excised and affixed onto a block of resin
for preparing 0.5-lm-thick semithin sections for light microscopic
observation, followed by ultrathin sections cut with an ultramicro-
tome (Ultracut E, Reichert-Jung, Vienna, Austria). Ultrathin sections
were stained with uranyl citrate and visualized in a transmission
electron microscope (Biotwin CM-100, Philips, Eindhoven,
Netherlands).
PV-KO and C57BL/6 mice (n 5 1 each) were transcardially
perfused with a solution of 2.5% Glutaraldehyde and 2% PFA in
Na-cacodylate buffer. Brains were post-fixed overnight and then cut
into 100mm-thick coronal sections with a vibratome (Vibratome
1000 Sectioning System, Technical Products International, St. Louis,
MO). The sections were post-fixed with 1% OsO4 and dehydrated
through graded ethanol concentrations. After embedding in epon,
the medial and lateral wall of the anterior lateral ventricle and the
hippocampal wall of the caudal lateral ventricle were excised and
affixed onto a block of resin for preparing 0.5-lm-thick semithin
sections for light microscopic observation, followed by ultrathin sec-
tions cut with an ultramicrotome (Ultracut E, Reichert-Jung,
Vienna, Austria). Ultrathin sections were stained with uranyl citrate
and visualized in a transmission electron microscope (Biotwin CM-
100, Philips, Eindhoven, Netherlands).
Scanning Electron Microscopy (SEM)
PV-KO and C57BL/6 (n 5 1 each) were transcardially perfused
with a solution of 2.5% glutaraldehyde and 2% PFA in Na-
cacodylate buffer. The lateral wall of the lateral ventricle was en-face
isolated as previously described (Mirzadeh et al., 2008), followed by
the isolation of the hippocampi. The specimens were post-fixed with
1% OsO4 and dehydrated through graded ethanol concentrations.
They were subjected to critical point drying with carbon dioxide and
then covered with a 20nm-thin gold layer. The specimens were
visualized in a Phenom Pro electron microscope (Phenom-World,
Eindhoven, Netherlands).
Primary Ependymal Cell Cultures
Primary ependymal cell cultures were generated by mechanical isola-
tion of the ventricular zone of the lateral ventricle walls from brains
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of newborn PV/cre/EGFP or Foxj1/EGFP mice. Mice were sacrificed
by decapitation, brains were excised and the region containing the lat-
eral ventricle wall was dissected in ice-cold PBS. Lateral ventricle wall
explants were enzymatically digested at 37C for 5 min in 0.05%
Trypsin/EDTA solution (GIBCO, LuBioScience, Lucerne, Switzer-
land) and resuspended in pre-warmed culture medium containing
DMEM supplemented with 10% fetal calf serum (GIBCO, LuBio-
Science, Lucerne, Switzerland) following centrifugation. Explants were
mechanically dissociated by gentle pipetting through fire-polished
glass pipettes of three different tip diameters. After centrifugation and
washing with PBS, cells were resuspended and plated in multiwell cell
culture plates (Nunc, Milan Analytica, Rheinfelden, Switzerland) at
150,000–200,000 cells mL21 in fresh cell culture medium.
In vivo Stereotactic Lesion of the Lateral Ventricle
Wall
C57BL6 (n5 8, of either sex) and PV-KO/EGFP (n5 4, of either sex)
adult mice (4- to 6-months-old) were used to perform in vivo stereotac-
tic mechanical lesion of the lateral ventricle wall. Animals were anesthe-
tized with Ketamine/Xylazine (100 and 10 mg kg21 body weight,
respectively) and the head was immobilized in a stereotactic apparatus
(Kopf Instruments, Tujunga, CA). A 0.5 mm2 opening was drilled into
the skull at the stereotactic coordinates and the lesion was carried out
unilaterally over the left lateral ventricle with a 1-mm-long-blade. The
stereotactic coordinates of the lesion were the following: mediolateral:
12.5 mm, rostrocaudal: from Bregma 21.0 mm to 22.0 mm, depth:
23.0 mm. After the blade penetrated the brain parenchyma, it was held
in position for 5 s, then removed. As control, one animal was sham-
operated, whereas it underwent the same procedure except for penetra-
tion of the blade into the brain parenchyma. To estimate the prolifera-
tion rate in the lateral ventricle zone of the mice which underwent the
in vivo injury, animals received cumulative BrdU (Sigma–Aldrich,
Buchs, Switzerland) injections intraperitoneally 24 h, resp. about 3 h
prior to transcardial perfusion at a concentration of 100 mg kg21 body
weight. Lesioned and sham-operated animals were transcardially per-
fused with a 4% PFA solution in 0.1M PBS (pH 7.4) on the 7th day
post-injury, the brains were removed and post-fixed overnight at 4C,
transferred to cryoprotectant solution (18% saccharose) and processed
for cutting 30-mm-thick-sections with a freezing microtome (Frigomo-
bil, Reichert-Jung, Vienna, Austria). Immunohistochemistry on free-
floating sections was performed with PV and BrdU antibodies. In
another set of experiments, lesioned C57BL/6 mice (n 5 3) were
allowed a survival time of 6 weeks post-injury before sacrifice.
Intraventricular Injection of Neuraminidase
Neuraminidase from Clostridium perfringens (Roche Diagnostics,
Rotkreuz, Switzerland) was dissolved in sterile 0.9% NaCl solution at
a concentration of 50 U mL21. Young adult C57BL/6 (n 5 9) and
PV-KO (n 5 9) male mice (3- to 4-months-old) were anesthetized
with Ketamine/Xylazine (100 and 10 mg kg21 body weight, respec-
tively) and the head was immobilized in a stereotactic apparatus (Kopf
Instruments, Tujunga, CA). One microliter of diluted neuraminidase
(0.15, 1.5, and 15 mU mL21) was delivered unilaterally to the rostral
lateral ventricle with a stereotactically placed 5 mL Hamilton microsyr-
inge. (Coordinates: 20.2 antero-posterior, 1-mm lateral and 2-mm
ventral relative to Bregma). Saline injection was performed in control
mice. Animals were transcardially perfused on the 4th day following
the intraventricular injection, the brains were cut into 40-mm-thick-
coronal sections and immunostained for GFAP, S100b, and PV. The
rostrocaudal series of coronal sections were then processed for meas-
urements of the lateral ventricle size (LV) and quantification of the
fluorescent intensity of the immunostainings. The LV size measure-
ment was performed on a series of 12 coronal sections—each at 240
mm from each other—at the same Bregma levels for each animal,
whereas the surface of the LV (in mm2) was divided by the surface of
the brain in each section. Thus, we obtained percentages over a coro-
nal series and did the statistical analysis comparing the LV/Brain sur-
face ratio in each treatment group. Similarly, we conducted the
measurement of the fluorescent intensities in the region of the ven-
tricles on 12 coronal sections at 240 mm using ImageJ software.
Visualization and Image Analysis
Image analyses were performed with a Leica TCS SP5 confocal laser
microscope (Leica, Germany), a Leica DMI6000 time-lapse fluores-
cent microscopy (Leica, Germany), a digital slide scanner Nano-
zoomer 2.0-HT (Hamamatsu Photonics France, Massy, France),
respectively with transmission electron microscopy (Biotwin CM-
100, Philips, Eindhoven, Netherlands). Image post-processing and
contrast adjustments were performed using ImageJ software, LAS AF
software (Leica, Germany) and Adobe Photoshop CS2.
Quantification of the Fluorescent Intensity
To assess the fluorescent intensity of the PV-immunostaining in the
ependymal-cell clusters after exposing OHSCs to compounds that
modify the oxidative stress level, the Leica Application Suite
Advanced Fluorescence software (LAS AF) from Leica Microsystems
(Leica, Germany) was used. Out of the control and treated groups,
three OHSCs were chosen for the analysis. In each slice, ependymal-
cell clusters were identified and several regions of interest (ROIs)
with a volume of 45 mm (x) 3 45 mm (y) were fixed in the
maximal-projection images recorded of ependymal-cell clusters
throughout their whole volume. The mean fluorescent intensity was
measured and displayed on a scale ranging from 0 to 255, corre-
sponding to the pixel intensities in eight-bit images. The mean val-
ues were calculated from each of these data sets per group. Statistical
analyses were performed applying the Student’s t test to compare dif-
ferent treatment groups to each other. Differences were considered
significant at P < 0.05.
Time-lapse Fluorescent Image Recording
Image sequences were obtained with an inverted fluorescent micro-
scope (Leica DMI6000) equipped with an environmental chamber at
constant temperature (37C). Brightfield and fluorescent images
were taken every 15–30 min for several days, respectively brightfield
images continuously recorded to assess cilia beating using the LAS
AF Software (Leica, Germany).
Antibody Array
The concentration of inflammatory mediators in the acutely dis-
sected organotypic hippocampal slices was estimated with a Mouse
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Cytokine Antibody array C3 (RayBiotech, Lucerna-Chem, Lucerne,
Switzerland). Hippocampi were dissected, sliced and maintained as
described above in serum-free medium, followed by the collection of
the medium supernatant 30 min, 2 h and 24 h after the preparation
of the OHSCs. A set of cytokines was semi-quantitatively measured
in the medium supernatant at different time points following the
manufacturer’s instructions.
Gene Microarray Experiment
OHSCs were generated from 7-day-old C57BL/6 (n 5 11, of either
sex) and PV-KO mice (n 5 10, of either sex) and maintained for 21
days in culture. On the 21st day in vitro (DIV21) the ependymal
aggregates were manually excised after identification of ependymal
clusters by the presence of beating cilia under a stereomicroscope.
The excised tissue was collected in 1.5ml Eppendorf tubes contain-
ing 350 mL RNA Lysis Buffer (Qiagen, Milan Analytica, Rheinfel-
den, Switzerland). The extracts were disrupted and homogenized
using 5-mm stainless steel beads (Qiagen) in a Tissue Lyser LT (Qia-
gen) for 2 min at 20 Hz. The tissue lysates were processed for purifi-
cation of total RNA using an RNeasy Plus Micro kit (Qiagen),
following the manufacturer’s instructions. The quantity of the
extracted total RNA was measured with a NanoDrop 2000 spectro-
photometer (Fisher Scientific, Wohlen, Switzerland) and Agilent
2100 bioanalyzer (Agilent Technologies, Palo Alto, CA). The RNA
quality and RIN (RNA integrity number) were assessed with the
RNA 6000 Pico Kit (Agilent). Samples with a RIN value lower than
7.6 were excluded from the experiment. Equivalent amounts of
RNA were pooled from three individuals out of nine C57BL/6 mice
and from three individuals out of nine PV-KO mice, resulting in
three sample series, each containing 105 ng RNA, for the wild-type
C57BL/6 samples (WT1-WT3) and three series for the PV-KO sam-
ples (PVKO1-PVKO3). The pooled RNA samples were stored at
280C until they were processed for the whole transcript amplifica-
tion by NuGEN OvationVR Pico WTA System V2 (NuGEN Tech-
nologies, San Carlos, CA). The whole transcript amplification,
labelling and gene chip hybridization on an Affymetrix Mouse Gene
1.0 ST Array (Affymetrix, Santa Clara, CA) were performed at the
Genomic Technologies Facility (GTF) at the University of Lausanne,
Switzerland. Hierarchical clustering was performed on fold-changes
calculated from normalized expression values on log2 scale using the
software “Expression Console” provided by Affymetrix (version
1.2.1.20). The genes with a statistically consistent fold-change were
selected for subsequent analysis. Statistical analysis of the data and
further clustering was performed with Multiexperiment Viewer
(MeV) v4.9 software (TM4 Microarray Software Suite, Dana-Farber
Cancer Institute, Boston, MA) following the developers’ instructions
as previously described (Saeed et al., 2003), respectively by Meta-
Core software from GeneGO (Thomson Reuters, New York, NY).
To discover potential diversity of biological processes between WT
and PV-KO ependymal cells, Gene Set Enrichment Analysis (GSEA)
(Subramanian et al., 2005) from Broad Institute of Massachusetts
Institute of Technology and Harvard (Cambridge, MA) was used.
Gene sets were compiled from Ncl, KEGG, PFAM, Biocarta, and
GO databases. GSEA analysis was performed using gene-set permu-
tations with a false discovery rate (FDR) cut-off of 5% and family-
wise error rate (FWER) of 5%.
Results
De Novo Expression of Parvalbumin in Ependymal
Cells of Organotypic Hippocampal Slice Cultures
(OHSCs)
During the course of culturing organotypic hippocampal slices,
we observed a de novo, ectopic expression of parvalbumin in a
region corresponding to the ventricular zone (VZ) lining the
lateral ventricle (Fig. 1A,B). Ependymal cells of the lateral ven-
tricle wall which do not usually express this calcium-binding
protein were found in cell-clusters corresponding to the epen-
dymal monolayer around the edge of the slices (Fig. 1A,B), and
had elongated, bipolar forms (Fig. 1C). To investigate if de novo
PV-expression is restricted to the ependymal lining of hippo-
campal slices, we prepared slice cultures from the lateral ventri-
cle wall covering the caudatoputamen. De novo expression of
PV was found also in the ependymal-cell clusters of the lateral
wall explants (Fig. 1D,D’). In both cases, PV-immunopositive
cells had a radial morphology and were found to be co-labeled
with the ependymal-cell marker S100b (Fig. 1D,D’). The
ependymal character of the PV-positive cells was confirmed by
the presence of cytoplasmic lipid droplets, a cell-surface fringe
of microvilli, lumen-formation and the existence of motile cilia
(Fig. 1E,E’), and by S100b-immunoreactivity (Figs. 1D,D’ and
2C). PV-driven expression of EGFP was observed prompt after
the onset of culturing, and the number of PV-positive cells in
the cultured ependymal monolayers increased with time (Fig.
1F). We observed and recorded beating cilia on the apical sur-
face of PV/EGFP-expressing ependymal cells in both organo-
typic hippocampal slice cultures and in primary ependymal-cell
cultures (Fig. 1G, Supporting Information Movie S1). In pri-
mary cultures, beating cilia were observed on the surfaces of the
PV-positive ependymal cells as late as DIV45 (Fig. 1G, Sup-
porting Information Movie S1). Beating cilia were also present
on other cells which did not express PV-driven EGFP. To inves-
tigate whether the up-regulation of PV influences cilia move-
ment, we quantified the cilia beating frequency between
ependymal cells that expressed PV-driven EGFP and that were
PV-negative. We found a beating frequency of 7.81 Hz 6 2.81
in PV1 cells and 8.28 Hz 62.06 in PV- cells, an insignificant
difference (P5 0.77) (Fig. 1H). Thus, we assume that the pres-
ence of PV in ependymal cells does not influence the cilia beat-
ing frequency.
PV-immunoreactive Ependymal Cells are Positive
for Foxj1, S100b, and CD-133
Under physiological conditions, ependymal cells are considered
to be post-mitotic and quiescent (Spassky et al., 2005). How-
ever, they have been described to undergo dedifferentiation in
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FIGURE 1: De novo parvalbumin-expression in ependymal cells in organotypic hippocampal slice culture (OHSC) and dissociated primary
ependymal-cell culture (PECC). (A) Overview image of a DIV7-OHSC after epon-embedding and 1% OsO4 treatment. Dashed outline
indicates the localization of the ependymal-cell cluster. (B) Confocal z-stack projection of an ependymal-cell cluster (marked by dashed
outline) at the ventricular zone (VZ) region in an OHSC specimen from a PV-Cre/EGFP mouse fixed at DIV7. PV-expressing cells are
EGFP-positive, whereas cells not expressing PV are DsRed-positive. (C) Confocal z-stack projection of PV-positive ependymal cells
revealed by PV-immunohistochemistry and DAPI staining in OHSC of a C57BL/6 mouse at DIV7. Cells form compact cell aggregates,
occasionally extending their cytoplasmic processes over the cell island. Bi- and multipolar cell shapes with elongated nucleus and cyto-
plasmic processes are visible. (D–D’) PV is expressed in ependymal-cell clusters of both the hippocampal wall and the lateral wall of the
lateral ventricle in DIV7 C57BL/6 slice cultures. Ependymal cells have a radial morphology and are co-labeled with S100b. (E–E’) Trans-
mission electron micrographs of ependymal-cell clusters of OHSCs of a C57BL/6 mouse fixed on DIV7 reveal ependyma-specific cell
organelles, such as lipid droplets, cilia, basal bodies and microvilli, and lumen-formation. (F) Live fluorescent time-lapse image sequence
of OHSCs from a PV-Cre/EGFP mouse showing increasing number of PV-expressing ependymal cells at six time points from DIV2 until
DIV28. Dashed ellipses indicate ependymal-cell clusters. (G) Live fluorescent and bright field images of primary ependymal cell culture
from a PV-Cre/EGFP mouse at DIV45. A subset of ependymal cells express PV-driven EGFP, display long cytoplasmic processes and pos-
sess motile cilia (red arrows). The boxed area is shown at higher magnification to visualize the motile cilia bundles (pointed at by pink
arrows) at the apical surface of ependymal cells. White stars mark motile cilia at the surface of PV-EGFP negative ependymal cells. (H)
The graph shows that the cilia beating frequency of PV-expressing and PV-negative ependymal cells does not differ significantly. Error
bars show the standard deviation. (PECC: primary ependymal cell culture, OHSC: organotypic hippocampal slice culture, DG: dentate
gyrus, cil: cilium, bb: basal body, mv: microvilli, nucl: nucleus, ld: lipid droplet, lu: lumen).
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FIGURE 2: PV-positive cells in the ependymal clusters are Foxj1-, S100b-, and CD133-positive and neural progenitor and precursor cells
are intermingled between them. (A) Confocal z-stack projection of PV-immunohistochemistry on OHSCs of a Foxj1/EGFP mouse at
DIV11 reveals a Foxj1/EGFP positive ependymal-cell cluster co-labeled with PV-antibody. Most of the cells emerging from the cell island
are double-labeled (white arrows and arrowheads), although some Foxj1/EGFP positive cells are PV-negative (green arrows) and some
PV-positive cells are Foxj1/EGFP negative (red arrows). (B–G) are confocal z-stack projections of immunostainings of ependymal-cell
islands in OHSC of C57BL/6 mice at DIV7. (B) GFAP is not co-labeled with PV (green arrowheads) in the same cells. (C) S100b-
immunostaining co-labels PV-immunopositive cells in the ependymal-cell clusters (see white arrowheads in the inset on the right). (D)
Nestin-immunopositive cell bodies (red arrowheads) and processes are intermingled between PV-immunopositive cells (green arrow-
heads), but no double-labeled cells were detected. (E) CD133-immunostaining co-labels some PV-immunopositive cells in the
ependymal-cell clusters (see white arrowheads). (F) Doublecortin-immunostaining (Dcx) reveals a Dcx-positive cell (red arrowhead) and
its processes intermingled between PV-positive ependymal cells (green arrowheads), however, no co-expression can be observed. (G)
Ki67-immunostaining reveals cell nuclei in the active phases of the cell cycle. Ki67-stained cell nuclei (red arrowheads) are found around
PV-positive ependymal cells. No labeling was detected in the cell nuclei of PV-positive cells (green arrowheads), suggesting that PV-
positive cells were not actively proliferating at the time of fixation at DIV7.
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response to strong stimuli such as mechanical injury (Carlen
et al., 2009). Indeed, a subpopulation of ependymal cells
expresses Prominin-1/CD133—a stem-cell marker (Coskun
et al., 2008). In OHSCs, we observed morphological features
similar to those described in “reactive” ependymal cells,
namely, the acquirement of radial and bipolar forms (Gregg
and Weiss, 2003). The remarkable fate plasticity of ependymal
cells (Nomura et al., 2010) gives rise to questions concerning
the origin of PV-expressing ependymal cells, as well as to their
potential to generate new cells and to contribute to the process
of niche-remodeling that follows tissue damage in OHSCs and
in vivo.
Foxj1-driven EGFP-expression in the brain is restricted
to ependymal cells and to a subset of progenitor cells derived
from the ventricular zone (Jacquet et al., 2009; Ostrowski
et al., 2003). Foxj1/EGFP-expressing murine pups were used
to study the morphology and the pattern of PV-expression in
ependymal cells of OHSCs. In the ependymal clusters, co-
labeling for Foxj1/EGFP and PV was observed in the ependy-
mal cells themselves, as well as in several cells that lay close to
the ependymal nest (Fig. 2A). The cells surrounding the
ependymal clusters manifested an elongated form and pro-
truded long cytoplasmic processes, which projected radially
from the nest. Most of the cells co-expressed Foxj1/EGFP
and PV (Fig. 2A). However, amongst the cells surrounding
the ependymal clusters, a few of the Foxj1/EGFP-expressing
ones were not PV-positive, suggesting that only a subpopula-
tion of the ependymal cells produce the CaBP.
To delineate the characteristics of the ependymal-cell
clusters, DIV7 OHSCs were subjected to co-immunostaining
for the astrocyte marker GFAP and the ependymal marker
S100b. Immunoreactivity for GFAP did not coincide with
the PV/EGFP-expressing cells (Fig. 2B), whereas that for
S100b did (Fig. 2C). This finding confirms that the PV-
positive cells in the ventricular niche are a subset of ependy-
mal cells.
Increase in the Number of PV-positive Cells Reflects
De novo PV-synthesis—Not Cell Proliferation
To investigate if PV-expressing ependymal cells retain prolifer-
ative or progenitor-like properties, immunostaining for Nestin
(a marker of neural stem cells), Prominin-1/CD133 (a marker
of ependymal cells and progenitors in the VZ), Doublecortin
(a marker of neural progenitors and of migrating neuroblasts)
and Ki67 (a marker of cell proliferation) was performed.
Immunoreactivity for nestin was disclosed in several cell
bodies and in cytoplasmic processes that ran between the PV-
positive ependymal cells. However, none of the nestin-positive
cell bodies co-expressed PV (Fig. 2D). Although ependymal
cells with a certain stem-cell capacity have been shown to
express CD133 (Coskun et al., 2008), their identity remains
controversial (Chojnacki et al., 2009; Kriegstein and Alvarez-
Buylla, 2009). Immunostaining for CD133 was observed in
the PV-positive cells (Fig. 2E), thereby confirming their epen-
dymal phenotype. The neuroblast marker Doublecortin was
not co-expressed with PV (Fig. 2F). However, as was observed
for nestin-immunoreactivity, long neural processes coursing
between the PV-positive ependymal cells were labeled. Ki67
is a marker of cell nuclei in the active phases of the cell cycle,
thus it marks cells that were proliferating at the time of fixa-
tion of the tissue. Immunostaining for Ki67 revealed most of
the PV-positive ependymal cells in the clusters to be non-
proliferative at DIV7, at the time-point of the fixation (Fig.
2G). However, owing to the dense organization of the PV-
positive ependymal cells, which rendered difficult an identifi-
cation of their borders, some degree of co-localization may
not be categorically excluded. Additionally, we cannot exclude
that PV-positive ependymal cells might have been proliferat-
ing earlier than DIV7, as Ki67 marks only the cell nuclei that
are currently in the active phases of the cell cycle. But even if
a few of the ependymal cells in the OHSCs had undergone
division, the hypothetically low proliferation rate could not
have accounted for the massive increase in the number of the
PV-positive ependymal cells. Hence, we believe that the
increase in the number of the PV-positive ependymal cells
that was observed in the OHSCs reflects the de novo expres-
sion of the CaBP in a continuously recruited population
rather than proliferative activity.
The Up-regulation of Parvalbumin in Ependymal
Cells is Injury-related and Facilitates Gap Closure
After a Scratch-Wound Inflicted to OHSC
To investigate the mechanism whereby PV-expression is trig-
gered in ependymal cells, OHSCs of PV-Cre/EGFP-mice
were subjected to a scratch-wound assay. Ependymal-cell
aggregates of DIV7 OHSCs were mechanically injured with
the tip of a sterile microdissector and PV-driven EGFP-
expression was monitored by time-lapse microscopy for 41 h
and followed up for 7 consecutive days. Twenty-nine h after
lesioning, cells adjacent to the site of injury manifested
increased EGFP-fluorescence intensity than did those at some
distance from the lesion (Fig. 3A). This finding suggests that
the mechanical lesioning of the cells can directly induce an
up-regulation of the parvalbumin gene. Seventy-two hours
after scratching, the cells adjacent to the lesion still showed
more intense EGFP-expression than did those further away
from it. Six, resp. seven days after scratching, EGFP-
fluorescence was homogenously distributed throughout the
ependymal cell mass, as was the case prior to wounding (Fig.
3A). Our findings indicate that the de novo expression of PV
that was observed in OHSCs might be a direct consequence
of the mechanical lesion that occurs during their preparation.
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FIGURE 3: Mechanical lesion of ependymal-cell clusters in OHSCs induces PV-upregulation in ependymal cells adjacent to the lesion. (A)
Time-lapse fluorescent image sequence of scratch-wound experiments in ependymal-cell clusters in PV-Cre/EGFP OHSCs shows increase in
PV-driven EGFP-expression in the cells adjacent to the scratch. About 29 h following the scratch, EGFP-expression is visibly stronger in
cells at the two edges around the lesion. At 72 h after scratch, EGFP-expression is still stronger around the mechanical lesion; whereas 6
and 7 days post-scratch, EGFP-expression appears more homogeneous. (B) Time-lapse bright field image sequence of PV-Cre/EGFP and
PV-KO ependymal scratches over 24 h reveal that PV-Cre/EGFP scratch rims approach each other more rapidly than their PV-KO counter-
parts. Ependymal-cell clusters are pseudocolored with orange; the background caused by the cell culture insert membrane was subtracted
in favor of a better visualization. (C and D) The scratch gap closing time of PV-Cre/EGFP and PV-KO ependymal scratches are presented as
percentages of the initial wound area (C) and as percentages of the initial median distance between the wound rims (D). The speed of the
regression is shown as a trendline with the corresponding equations. The wound area is decreasing consistently in both PV-Cre/EGFP and
PV-KO lesions, although more rapidly in PV-Cre/EGFP (C) (P 5 0.01 at 6 h and <0.005 starting from 9 h). Likewise, the median wound dis-
tance shows a faster decreasing tendency in PV-Cre/EGFP as compared with PV-deficient ependymal-cell clusters (D) (P < 0.05 at 3 h and
<0.001 starting from 6 h). (E) The graph shows that the motion of the EGFP1 cells over 24 h around the wound rims is higher following the
scratch in PV-Cre/EGFP than in PV-KO/EGFP mice. The motion of unlesioned EGFP1 cells (5control cells) of both PV-Cre/EGFP and PV-
KO-EGFP were also measured: no significant difference can be found between their cell motility. (F) Time-lapse image sequences show the
movement of EGFP1 ependymal cells over 24 h next to a scratch (the position of the scratch is marked by dashed red line). PV-Cre-EGFP1
cells (tracked with colored arrow) show considerable cell shape alterations and move closer to the scratch line while their PV-KO/EGFP1
counterparts (tracked with colored arrow) display virtually no major movement. Error bars show the standard deviation. (***: P < 0.0005).
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Next, we compared the kinetics of wound closure following a
mechanical scratch at the continuous ependymal-cell cluster
in OHSCs of C57BL/6 (n 5 3), PV-Cre/EGFP (n 5 3),
PV-KO (n 5 3), and PV-KO-EGFP (n 5 3) mice. The suc-
cess rate for scratch closure in the C57BL/6 and PV-Cre/
EGFP ependymal cell clusters was over 80%, whereas a low
percentage of 30% was observed in PV-KO ependymal clus-
ters (examples shown in Fig. 3B). Quantification of the
wound area over time showed that the PV-KO lesions indeed
remained larger than those of the PV-Cre/EGFP lesions
(69.6% of the initial wound area 69.1% for PV-KO com-
pared with 27.7% 6 5.8% for PV-Cre/EGFP after 41 h, Fig.
3C). The scratch-wound area was significantly larger in PV-
KO ependymal-cell clusters as compared with their wild-type
counterparts starting at 6 h post-scratch (P 5 0.01), and the
difference increased over time (9 h post-scratch P 5 0.001,
from 12 h until 41 h post-scratch P < 0.001). This phenom-
enon was even more prominent when we examined the dis-
tance between wound edges over time: the median wound
edge distance was 85.2% 611.7% for PV-KO and 23.7% 6
11.6% for PV-Cre/EGFP after 41 h (Fig. 3D). The wound
edge distance in PV-KO ependymal-cell clusters was signifi-
cantly larger as prompt as 3 h post-scratch (P 5 0.02), and
similarly to the wound area, the difference increased over
time (at 6 h post-scratch P 5 0.0008, from 9 h post-scratch
until 41 h post-scratch P < 0.0001). Thus, we conclude that
in OHSCs a mechanically disrupted ependymal cell layer has
the capacity of re-establishing a continuous layer, and this
capacity is impaired in PV-deficient ependymal cells.
Next, we examined the motility of PV-positive ependy-
mal cells around the lesion based on their PV-driven EGFP
expression, and compared it to that of PV-KO-EGFP cells.
This strain cannot transcribe PV: 85% of the Pvalb-gene-
coding sequence is replaced with the phosphoglycerate-kinase
(PKG) neo-cassette (Schwaller et al., 1999); the activity of the
promoter is, in contrast, unaffected and drives the expression
of EGFP. Hence, using this murine strain, PV-deficient cells
can be visualized and followed-up. Generally, in PV-Cre/
EGFP slices, EGFP1 cells around the lesion showed a
remarkable motility and cell shape alteration in contrast to
the PV-deficient ones (Fig. 3F). We measured the absolute
motion of EGFP1 cells around the scratch from the start-
point of the lesion until 24 h later, and we found that the
ependymal cells expressing PV moved considerably more than
those lacking PV (Fig. 3E,F). PV-Cre/EGFP ependymal cells
around the lesion moved 41.3 mm 6 17 mm in 24 h, while
PV-deficient cells moved only 17.5 mm 6 12.3 mm (P <
0.00001). In comparison, the motion of EGFP1 cells of the
control, unscratched ependymal-cell clusters was around 12.2
mm 6 5.7 mm in PV-Cre/EGFP ependymal clusters and
10.48 mm 6 4.1 mm in the PV-KO-EGFP ones (Fig. 3E),
moderately higher in PV-expressing ependymal cells, although
not significantly (P 5 0.1). This suggests that PV-expressing
ependymal cells have an enhanced motility following the dis-
ruption of the continuous layers. PV-deficient ependymal
cells, in contrast, have a significantly more restricted motility.
Next, we addressed the question if the impairment seen
in the scratch-wound closing kinetics of the ependymal-cell
clusters of PV-deficient slices could be caused by a more
extensive degree of cell death following scratching compared
with their wild-type counterparts. We assessed the degree of
cell death by two independent approaches suggested by previ-
ous studies in organotypic slice culture systems, namely quan-
titation of lactate dehydrogenase (LDH) release into the
medium and propidium iodide (PI) uptake (Lossi et al.,
2009). We measured the baseline degree of cell death 1 h
prior to scratching in all the inserts and slices in both WT
and PV-KO (n 5 3, 10 OHSCs/well, total number of
scratched OHSCs 5 60 for each), then repeated measure-
ments 1 h, 8 h, 24 h, 48 h, 72 h and 1 week after scratching
and compared the values to unlesioned control (n 5 2, 10
OHSCs/well, total number of control OHSCs 5 40 for each
WT and PV-KO). The quantitative approach of LDH activity
measurement revealed significantly increased LDH efflux
(P < 0.05, Student’s t test) from scratched ependymal-clusters
in both WT and PV-KO at 1 h post-scratch (5.6 mU mL21
6 0.9 mU mL21 vs. 1.7 mU mL21 6 0.5 mU mL21 in
WT; 5.3 mU mL21 6 0.4 mU mL21 vs. 2.0 mU mL21 6
0.5 mU mL21 in PV-KO), 8 h post-scratch (7.0 mU mL21
6 0.8 mU mL21 vs. 3.2 mU mL21 6 0.1 mU mL21 in
WT; 7.5 mU mL21 6 1.0 mU mL21 vs. 2.2 mU mL21 6
0.5 mU mL21 in PV-KO), 24 h post-scratch (10.5 mU
mL21 6 1.1 mU mL21 vs. 3.8 mU mL21 6 0.3 mU mL21
in WT; 11.5 mU mL21 6 1.5 mU mL21 vs. 4.8 mU mL21
6 0.4 mU mL21 in PV-KO), 48 h post-scratch (11.9 mU
mL21 6 1.0 mU mL21 vs. 6.7 mU mL21 6 0.7 mU mL21
in WT; 10.7 mU mL21 6 1.3 mU mL21 vs. 4.0 mU mL21
6 0.4 mU mL21 in PV-KO) and 72 h post-scratch (15.5
mU mL21 6 2.0 mU mL21 vs. 8.9 mU mL21 6 1.2 mU
mL21 in WT; 17.0 mU mL21 6 1.9 mU mL21 vs. 9.0 mU
mL21 6 0.8 mU mL21 in PV-KO) when compared with
unlesioned control (Fig. 4A). After 1 week, LDH activity was
similar to the pre-scratch values from both scratched and con-
trol slices (2.2 mU mL21 6 0.9 mU mL21 in WT; 1.5 mU
mL21 6 0.6 mU mL21 in PV-KO). Next, we compared if
LDH activity differed between WT and PV-KO scratched sli-
ces after subtracting the background of the control slices’
activity. We found no significant difference in none of the
time-points of the measurements (Fig. 4B; pre-scratch 1.4
mU mL21 6 0.3 mU mL21 in WT vs. 2.5 mU mL21 6
0.5 mU mL21 in PV-KO, P 5 0.07; 1 h post-scratch 3.9
mU mL21 6 0.9 mU mL21 in WT vs. 3.3 mU mL21 6
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FIGURE 4: Mechanical lesion of ependymal-cell clusters in OHSCs induces cell death in ependymal cells adjacent to the lesion; the
degree of cell death measured by LDH release and PI uptake does not differ significantly between PV-KO and their wild-type counter-
parts. (A) LDH (lactate dehydrogenase) activity (in mU mL21) in the culture medium of scratched and control ependymal clusters of
C57BL/6 OHSCs was detected by a colorimetric assay at seven different time-points (1 h pre-scratch, 1 h, 8 h, 24 h, 48 h, 72 h, and 1
week post-scratch). LDH activity was significantly higher in the medium supernatant of scratched slices than in that of control slices at 1,
8, 24, 48, and 72 h following the lesion. The increase in LDH activity dropped to non-significant in the culture medium 1 week following
mechanical lesion. Error bars show SEM. (*: P < 0.05, **: P < 0.005, Student’s t test). (B) LDH activity (in mU mL21) in the culture medium
of scratched ependymal clusters of C57BL/6 and PV-KO OHSCs at different time-points following background subtraction (LDH activity
of the control slices) show increase in cell death in both WT and PV-KO following scratching as compared with the pre-scratch levels.
The level of LDH activity drops to pre-scratch levels at 1 week after scratching. There is no significant difference between LDH activity
measured in scratched PV-KO and WT slices in none of the time-points. (C) Time-lapse image sequence of propidium iodide (PI, red)
uptake merged with the brightfield images in WT ependymal-cell cluster before and 1 h, 8 h, 24 h, 48 h, 72 h, and 1 week following
scratching. (D) Time-lapse image sequence of propidium iodide (PI, red) uptake merged with the brightfield images in PV-KO ependy-
mal-cell cluster 1 h pre-scratch and 1 h, 8 h, 24 h, 48 h, 72 h, and 1 week following scratching.
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0.4 mU mL21 in PV-KO, P 5 0.55; 8 h post-scratch 3.8
mU mL21 6 0.8 mU mL21 in WT vs. 5.2 mU mL21 6
1.0 mU mL21 in PV-KO, P 5 0.27; 24 h post-scratch 6.7
mU mL21 6 1.1 mU mL21 in WT vs. 6.7 mU mL21 6
1.5 mU mL21 in PV-KO, P 5 0.97; 48 h post-scratch 5.2
mU mL21 6 1.0 mU mL21 in WT vs. 6.8 mU mL21 6
1.3 mU mL21 in PV-KO, P 5 0.34; 72 h post-scratch 6.5
mU mL21 6 2.0 mU mL21 in WT vs. 8.0 mU mL21 6
1.9 mU mL21 in PV-KO, P 5 0.61; 1 week post-scratch 2.2
mU mL21 6 0.9 mU mL21 in WT vs. 1.7 mU mL21 6
0.6 mU mL21 in PV-KO, P 5 0.63). We also confirmed
these results by visually observing propidium iodide uptake at
the same time-points as above in both WTand PV-KO scratched
slices (Fig. 4C,D). By the visualization of PI uptake in several
scratched slices, qualitatively we could observe large amount of
dead cells in the scratch and in its vicinity, whereas the spared
ependyma adjacent to the scratches showed only minimal PI
uptake in few single cell nuclei in both WTand PV-KO. A quan-
titative analysis, e.g. number of dead cells proved to be difficult
due to the excessive cell debris - emitting strong patch-like red
fluorescence—found in the scratch-wound (Fig. 4C,D), never-
theless, by carefully observing all the scratched WT and PV-KO
slices, there appeared to be abundant PI-uptake in the cell nuclei
in the cell debris of the scratch wounds, confirming the result of
the LDH activity quantitation.
Up-regulation of Parvalbumin in the Ependymal
Cells of OHSCs can be Inhibited by Blocking NF-RB
and Decreased by Antioxidant Treatment
The observation that the de novo expression of PV in ependymal
cells follows injury raises the question as to which factors are
involved in the induction process. In an experimental model of
acute inflammation induced by a peripheral injection of lipo-
polysaccharides, the transcriptome of the choroid plexus—a
double-layered fold of the pia mater that is covered with a sheet
of ependymal cells—manifested an early increase in the expres-
sion of chemo- and cytokines (IL-6, IL-1b, TNF-a, etc.), as well
as in that of the inflammatory regulator transcription factor NF-
RB (Marques et al., 2009). Because ependymal cells express cyto-
kine receptors on their basolateral membrane (Marques et al.,
2011), we wondered whether the expression of PV could be
induced by inflammatory cytokines or by their mediators.
To identify the nature of the soluble cytokines that were
present in OHSCs, aliquots of the supernatant medium were
withdrawn for analysis at defined intervals after the preparation
of the OHSCs from C57BL/6 mice. A cytokine-antibody array
was utilized for this purpose. The analysis revealed the culture
medium to contain a broad spectrum of cytokines. About 24 h
after the onset of culturing, IL-6 was expressed at the highest
level, with a remarkable presence of VCAM-1, G-CSF,
CXL16, and sTNFRI (Fig. 5A). Hence, during preparation
and culturing of OHSCs, intrinsic cells of the slices do indeed
secrete inflammatory cytokines, any of which could potentially
play a role in the induction of PV-expression.
NF-RB-signaling is involved in cellular responses to strong
stimuli, such as stress and inflammation. By regulating the expres-
sion of cytokines and growth factors, NF-RB-signaling controls
the survival of cells and the immune response (Ghosh et al.,
1998). We observed that blockage of NF-RB-signaling led to an
almost complete inhibition of PV-expression in the ependymal
cells of OHSCs by DIV5 (Fig. 5B). When exposing the dissection-
and culturing medium of OHSCs of PV-Cre/loxP-DsRed-loxP-
EGFP mice to inhibitors of the NF-RB-signaling, PV-driven
EGFP was present only in a few scattered cells in the region of the
ependymal-cell cluster, while most ependymal cells expressed
DsRed. In contrast, the control, untreated ependymal-cell clusters
displayed numerous cells that expressed PV-driven EGFP (Fig.
5B). This finding suggests that the de novo PV-synthesis in ependy-
mal cells is dependent on NF-RB-signaling. Inflammation via
NF-RB-signaling might result in the upregulation of the Pvalb
gene also in other epithelial systems, based on gene-expression data
collected from the GEO Profiles DataBase (NCBI). Pvalb was
upregulated in skin cells in an inflammatory skin phenotype
mouse model with keratinocyte-specific IjB kinase beta (IKKbeta)
overexpression (GEO Accession: GDS3766); likewise, in the pros-
tate epithelium in a mouse model for inflammatory signaling
based on expression of a constitutively active version of IjB kinase
2 (IKK2ca) (GEO Accession: GDS4119).
To ascertain whether the injury-induced expression of
PV in ependymal cells is mediated by an elevated level of oxi-
dative stress, OHSCs were exposed to either N-acetyl-cysteine
(NAC) or buthionine sulfoximine (BSO). NAC suppresses
the production of reactive oxygen species, whereas BSO
inhibits the activity of gamma-glutamylcysteine synthetase,
whereby the level of gluthatione is reduced and the degree of
oxidative stress thereby heightened. PV-immunoreactivity was
observed in ependymal cells by DIV7 in each case (Fig. 5C).
Next, we quantified the mean fluorescent intensity of the PV-
immunostaining to estimate the amount of this CaBP present
in the ependymal-cell clusters. The quantification revealed the
fluorescent intensity of the PV-immunostaining to be signifi-
cantly lower after NAC-treatment than that of the control,
untreated slices (Fig. 5D). This effect was dose-dependent:
the fluorescent intensity of the PV-immunostaining was lower
after exposing the slices to 500 mM NAC than when exposed
to 100 mM NAC. In contrast, exposure to BSO did not result
in a significant difference in the fluorescent intensity of the
PV-immunostaining as compared with the control slices (Fig.
5D). The findings indicate that exposure of the culture
medium to antioxidants decreases the injury-evoked induction
of PV-synthesis, whilst exposure to stronger oxidative stress
has no influence on it.
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FIGURE 5: Regulation of PV-expression in ependymal cells by inflammatory regulator NF-RB, oxidative stress and EGFR signaling. (A) A
cytokine antibody array was performed to reveal cytokines present in the medium supernatant 30 min, 2 h, and 24 h after the prepara-
tion of OHSCs of C57BL/6 mice. Some inflammatory cytokines exhibited a massive increase after 24 h, such as IL-6, GCSF, VCAM-1,
MIP-1g (marked by red rectangles). Other cytokines decreased in concentration, e.g. VEGF, TNF-alpha, CD30 (marked by blue rectan-
gles). (B) Live fluorescent images of ependymal-cell clusters (marked by dashed ellipses) in OHSC of a PV-Cre/EGFP mouse at DIV5
treated with the NF-RB inhibitor Act (100nM), as compared with untreated controls show that NF-RB inhibition results in decreased PV-
driven EGFP expression in almost all ependymal cells. Control ependymal cells, in contrast, show intense PV-promoter driven EGFP
expression. Cells not expressing PV are DsRed-positive. (C) Confocal laser micrographs of ependymal-cell clusters in OHSCs of a C57BL/
6 mouse fixed on DIV7 treated with modulators of oxidative stress and immunostained for PV. Slices were treated with the antioxidant
N-acetyl-cysteine (NAC) to reduce oxidative stress or with the GSH-synthesis inhibitor buthionine sulfoximine (BSO) to enhance oxidative
stress. (ROS: reactive oxygen species). (D) The mean fluorescent intensity of the PV-staining shows lower intensity values in ependymal-
cell clusters treated with NAC than in untreated control or following BSO treatment. E.) Live fluorescent images of ependymal-cell clus-
ters (marked by dashed ellipses) in OHSC of a PV-Cre/EGFP mouse at DIV5 treated with EGFR-inhibitor (50mM), as compared with
untreated controls show that in treated slices, PV-expression is restricted to some single cells, whereas the untreated control
ependymal-cell cluster expresses abundant PV-driven EGFP. Error bars show the standard deviation. (**P < 0.005; ***: P < 0.0005).
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Our experiments reveal the de novo expression of PV to
be related to the injury-induced secretion of inflammatory
mediators. The level of PV-production in ependymal cells is
inversely proportional to the degree of oxidative stress. Given
that PV-positive interneurons are highly susceptible to
oxidative-stress-induced damage (Cabungcal et al., 2006), this
is a surprising finding. After treatment with BSO, the num-
ber of PV-positive interneurons in OHSCs did indeed drop
significantly, whereas after NAC-treatment a slight increase in
this parameter was observed (data not shown). These findings
indicate that the expression of PV is regulated differently in
reactive ependymal cells and in PV-positive interneurons.
Up-regulation of Parvalbumin is Modulated by
EGFR-signaling: A Possible Role in Injury-Induced
Remodeling
Signaling via the epidermal growth factor receptor (EGFR) indu-
ces radial-glial phenotype in the ependymal cells (Gregg and
Weiss, 2003). It also plays a role in injury-induced tissue remod-
eling: wounding of epithelia triggers the activation of the EGFR,
which is implicated in the induction of cell motility (Block and
Klarlund, 2008). Acting on EGFR, TGF-a was shown to induce
a massive increase in the rate of proliferation of SVZ- and VZ-
cells after injury (Fallon et al. 2000; Gleason et al., 2008). Fol-
lowing spinal cord injury, EGFR is upregulated by glial progeni-
tors and an intrinsic EGFR activation is necessary for normal
glial scar formation (White et al., 2011). Furthermore, the
administration of EGF to mice that have been subjected to cere-
bral ischemia leads to a replenishment of PV-positive neurons in
the injured striatum (Teramoto et al., 2003).
We investigated the possibility that the de novo expres-
sion of PV in ependymal cells might depend upon EGFR-
signaling by exposing OHSCs of PV-Cre/loxP-DsRed-loxP-
EGFP mice to the EGFR inhibitor cyclopropanecarboxylic
acid-dianilinopyrimidine (50 lM) (Fig. 5F). The result was
similar to that observed after the inhibition of NF-RB-signal-
ing: PV-driven EGFP was absent from most ependymal cells
by DIV5, when compared with the untreated control. Indeed,
ependymal cells of the OHSCs exposed to EGFR-inhibitor
displayed DsRed, while most untreated ependymal cells
expressed EGFP (Fig. 5F). This suggests that PV-synthesis
was inactive in ependymal cells when EGFR-signaling was
counteracted. In the light of this finding, we hypothesize that
injury and the ensuing process of remodeling might activate
EGFR signaling, which in turn induces—directly or indi-
rectly—the expression of PV in ependymal cells.
The Lack of Parvalbumin in PV-Knock-Out Mice
Influences the Organization of Ependymal Cells in
OHSC
Adult wild-type and PV-KO mice have a similar, normal
ependymal phenotype both at the lateral wall of the anterior
lateral ventricle and at the lining of the hippocampus (Fig.
6A,B), suggesting that PV-deficiency does not influence the
normal development and the function of the ependymal cells
under physiological conditions.
Next, we investigated the degree to which the absence
of PV influences ependymal cell phenotype following an
injury. For this purpose, we used OHSCs of C57BL/6 and
PV-KO/EGFP mice.
To investigate the consequences of a lack of PV in epen-
dymal cells, the OHSCs of PV-KO/EGFP mice were main-
tained for several weeks, followed by fixation at different
time-points after the onset of culturing, and their morpholog-
ical features were compared with those of their wild-type
(WT) counterparts. After 1 week of culturing, the EGFP-
expressing cells that were derived from the PV-KO/EGFP
mice were less tightly packed than were their PV-expressing
wild-type counterparts (Fig. 7A). After 2 weeks, the EGFP-
immunostained ependymal cells were sparser, less well organ-
ized and more irregular in shape than were their PV-
expressing counterparts. After 3 and 4 weeks, respectively, the
difference between the ependymal clusters of PV-KO and
wild-type mice became progressively more pronounced: the
PV-KO/EGFP-positive cells were sparse and often made con-
tact with each other via cytoplasmic processes, not via their
cell bodies (Fig. 7A). Transmission electron microscopy
revealed additional morphological changes (Fig. 7B). At
DIV7, the contacting cell membranes of adjacent ependymal
cells in wild-type OHSCs were characterized by widespread
interdigitations, which were maintained until DIV31. In the
OHSCs of PV-KO/EGFP mice, the intercellular connections
were looser at DIV7, yawning gaps existed between neighbor-
ing cells and the interdigitations were less prominent. At
DIV31, interdigitations were seldom observed and the inter-
cellular contacts were characterized by smooth surface con-
tours. Our findings indicate that in tissue cultures, the
absence of parvalbumin has a profound influence on the mor-
phology of ependymal cells and on their organization,
revealed by the loosening of the intercellular connections.
This could be the consequence of an impaired adaptation to
the altered physiological conditions found ex vivo in the
absence of parvalbumin.
A Comparative Gene-microarray Analysis of PV-KO
Ependymal-cell Aggregates Reveals Major
Differences at the Gene Expression Level, Including
Genes Implicated in Cytoskeletal Remodeling and
in the Response to Hypoxia
To improve our understanding of the molecular mechanisms
that contribute to the fine-tuning of PV-expression, and to
identify the genes that are differentially regulated in the cas-
cade of events following injury, ependymal cells that were
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isolated from the DIV21-OHSCs of wild-type and PV-KO
mice were subjected to a comparative whole-transcriptome
analysis (Fig. 7C,D). Using a fold-change cut-off level of 2
at an adjusted P value of 0.05%, 576 genes were down-
regulated and 346 up-regulated in the ependymal cells of PV-
KO mice. That so many genes were differentially expressed in
the ependymal cells of the two strains of mice suggests that
the absence of PV has a profound influence on their basic
physiological activity. To elucidate the pathways and processes
that might be implicated in the response of PV-expressing
ependymal cells to injury, we concluded a GeneGo and Gene
Set Enrichment Analysis (GSEA) on the genes that were dif-
ferentially expressed in the ependymal cells of the two strains
of mice at a fold-change cut-off level of 1.5 and an adjusted
FIGURE 6: Ependymal cells of the lateral ventricle in the adult murine brain retain a healthy ultrastructure in both C57BL/6 and PV-KO
mice. (A and B) As shown by transmission (A) and scanning (B) electron micrographs, wild-type and PV-KO adult mice possess a normal-
appearing ependymal cover at the lateral wall of the anterior lateral ventricle (level of the caudatoputamen) and at the medial wall at
the level of the hippocampus.
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FIGURE 7: Ultrastructural changes in aged ependymal cell-clusters of PV-KO/EGFP OHSCs reveal loosening of the ependymal-cell organization
and a simultaneous disappearance of intercellular interdigitations in the absence of PV. (A) Confocal z-stack projections comparing PV-
immunohistochemistry in wild-type ependymal-cell clusters to EGFP-immunohistochemistry in PV-KO/EGFP ependymal-cell clusters in OHSCs from
DIV7 until DIV28. In wild-type mice, PV-immunohistochemistry reveals compact, dense organization of ependymal cells from DIV7 until DIV28 in
the ependymal-cell clusters. In PV-KO/EGFP ependymal-cell clusters, cells are less densely packed at DIV7, and lose contact over time. (B) Transmis-
sion electron micrographs of wild-type and PV-KO/EGFP ependymal cells of OHSCs at DIV7 and at DIV31, labeled with PV-, resp. EGFP-
antibodies, and revealed by DAB confirm these findings. Single DAB-stained cells were pseudocolored to better distinguish between cell borders.
Wild-type ependymal cells appear packed together with neighboring cells, and display intensive interdigitations of the lateral cell membranes at
the sites of intercellular junctions at DIV7, which can be observed at DIV31 as well. In comparison, DIV7 PV-KO/EGFP ependymal cells display wider
gaps in between neighboring cells and their intercellular surface appears smoother. At DIV31, PV-KO/EGFP ependymal cells are scattered and
have lost connections and interdigitations. (C andD) A genemicroarray study was performed to understand the differences at the gene expression
level between wild-type and PV-KO ependymal-cell aggregates of DIV21 OHSCs. (C) Out of the selected up-regulated genes, 77 are involved in
hypoxia-induced stress responses and cell cycle arrest, 13 in cell adhesion and cell junctions, 28 in extracellular matrix remodeling and cell-matrix
interactions, and 43 genes are mitochondria-associated. (D) Among the selected down-regulated genes in PV-KO extracts, 79 are involved in the
regulation of cytoskeleton remodeling, 24 in cell adhesion and cell junctions, 53 in cell division, and different phases of mitosis and cytokinesis.
17
ht
tp
://
do
c.
re
ro
.c
h
p value of 0.05%. GeneGO analysis revealed the differential
expression of numerous pathways and biological processes.
The pathways that were notably impacted included those that
are involved in the remodeling of the extracellular matrix
(ECM), in the remodeling of the cytoskeleton, in the regula-
tion of Rho/Rac/Cdc42 pathways involved in cell motility, in
cell adhesion and in cell-matrix interactions. In the ependy-
mal cells of the PV-KO mice, down-regulated genes included
those that are involved in the rearrangement of the cytoskele-
ton, in ephrin-signaling, in microtubule- and spindle-
assembly, in the initiation of mitosis and cell division, and in
the general immune response (e.g., phagocytosis- and
chemotaxis-related genes). Up-regulated genes included those
that are involved in the responses to hypoxia and oxidative
stress, the remodeling of the ECM, in cell–matrix interactions
and in glutathione metabolism. We postulated that the crucial
processes underlying the differences between the injured epen-
dymal cells of wild-type and PV-KO mice impacted cytos-
keletal remodeling. This process is necessary to enhance the
motility of the cells, which permits their re-adaptation to
changes in the microenvironment and to injury-induced
stress. In the ependymal cells of the PV-KO mice, a subset of
genes (such as Ank3, Rhob, Rhog, Pak1, Vav1, Wasf1, Arpc1a,
Arpc1b, Cdc42ep1, Rap1a) that is involved in the regulation
of cytoskeletal rearrangement was indeed down-regulated
(Table 2), thereby implying impairment in the regulation of
cell motility and cell shape. In contrast, 34 genes that are
involved in the responses of cells to hypoxia and oxidative
stress (such as Hmox1, Gadd45a, Lox, Nupr1, Gss, Gsr, Gsta3,
Gstm2, Cebpb, Fosl1) were up-regulated in PV-KO (Table 2).
However, 7 genes that are likewise involved in the response
to hypoxia were down-regulated, thereby indicating that alter-
native mechanisms may be operative at the absence of PV. A
number of other genes were also differentially expressed in
the ependymal cells of the two strains of mice. These
included those that are involved in cell adhesion and in the
regulation and assembly of cell junctions. A set of genes
encoding mitochondrial proteins and enzymes was up-
regulated in the ependymal cells of PV-KO mice. This find-
ing accords with existing data that point to an inverse correla-
tion between the PV-content and mitochondrial volume of
different cell types (Chen et al., 2006).
Using GSEA analysis at a cut-off level of false discovery
rate (FDR) of <0.05% and family wise error rate (FWER) of
<0.05%, seven gene sets were positively enriched in the epen-
dymal cells of the PV-KO mice; one was negatively enriched.
The positively enriched gene sets were those that are involved
in the response to hypoxia and in the response of cancer cells
to treatment with receptor tyrosine kinase (RTK)-inhibitors,
Ras-inhibitors and arsenic trioxide. These findings indicate
that in the ependymal cells of the PV-KO mice, the levels of
general stress, hypoxia and growth inhibition were increased.
The single gene set that was negatively enriched in the epen-
dymal cells of the PV-KO mice is implicated in the develop-
ment of oligodendrocytes. However, in the present study, we
did not investigate whether the development of oligodendro-
cytes and their myelinating capacity are related to the injury-
induced de novo expression of PV in ependymal cells.
Parvalbumin is Up-regulated in Ependymal Cells
After In vivo Injury of the Lateral Ventricular Wall
To ascertain whether the injury-induced up-regulation of PV
in the ependymal cells occurs also in vivo, the lateral ventricle
wall of adult wild-type and PV-KO/EGFP mice was lesioned
with a stab-wound (Fig. 8A,B). Seven days after lesioning the
animals were transcardially perfused and the brains were proc-
essed for immunohistochemistry. Seven days post-injury, the
ependymal layer on the injured side manifested PV-
immunoreactivity (Fig. 8C,E), whereas in that of the sham-
operated mice (not shown) and in that on the uninjured side
no immunoreactivity for PV was observed in the lateral ven-
tricle wall (Fig. 8D,E’). Six weeks following lesioning, PV-
immunoreactivity was still present in the ependymal layer
adjacent to the stab lesion (Fig. 8F), although at a more mod-
erate level than at 1-week-post-injury; whereas it was virtually
absent on the unlesioned side (Fig. 8F’). PV-immunostaining
of the ependymal layer occurred along the entire length of
the lesion, as was revealed by the inspection of 1-week-post-
injury consecutive coronal sections (Fig. 8G–G’’’). In PV-KO/
EGFP mice (in which the parvalbumin-promoter is active,
although no PV is produced), the ependymal layer manifested
intense immunoreactivity for EGFP 1-week-post-injury (Fig.
8H–H’’’, 8J). These findings suggest that the lesioning of the
lateral ventricle wall activates the Pvalb-promoter in the epen-
dymal cells. However, while in wild-type mice PV-
immunoreactive cells occurred both in the ependymal layer
and in the vicinity of the lesion (Fig. 8I), in the PV-KO/
EGFP mice EGFP-immunoreactivity was confined to cells of
the ependymal layer (Fig. 8J). Lesioned wild-type mice mani-
fested wound-closure and scar formation around the lesion,
while these were virtually absent from PV-KO/EGFP mice.
We also performed GFAP immunostaining to mark reactive
astrocytes around the injury and the VZ (Fig. 8I,J). We found
that numerous astrocytes were present around the lesion in
both PV-KO-EGFP and wild-type mice; however, a scar tissue
with massive GFAP staining was present only in the wild-type
(Fig. 8I). In addition, in the cells of the scar tissue that
reunited the wound rims, GFAP and PV were co-localized in
the same cells (inset, Fig 8I), suggesting that scar forming
astrocytes might also express the CaBP. We have observed
PV-immunopositive cells in the stab-wound region also 6-
weeks-post-injury (inset, Fig. 8F) just above the ependymal
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TABLE 2: Genes Differentially Expressed in WT and PV-KO Ependymal Cells in DIV21-OHSCs
ID Fold
change
adj.P.Val Gene
symbol
Gene description
Cytoskeletal rearrangement, regulation of cell shape and cell motility
10527430 21.83 0.0048919 Arpc1a actin related protein 2/3 complex, subunit 1A
10527441 21.57 0.028817 Arpc1b actin related protein 2/3 complex, subunit 1B
10363786 23.64 0.0006517 Ank3 ankyrin 3, epithelial
10530100 21.69 0.004705 Arap2 ArfGAP with RhoGAP domain, ankyrin repeat and PH
domain 2
10413771 21.77 0.0278853 Capn7 calpain 7
10545538 22.02 0.0025788 Ctnna2 catenin (cadherin associated protein), alpha 2
10425116 22.41 0.0023557 Cdc42ep1 CDC42 effector protein (Rho GTPase binding) 1
10465278 25.83 0.0001519 Cdc42ep2 CDC42 effector protein (Rho GTPase binding) 2
10568024 22.89 0.0003017 Coro1a coronin, actin binding protein 1A
10356020 26.95 6.51E-05 Dock10 dedicator of cytokinesis 10
10385118 22.40 0.008793 Dock2 dedicator of cyto-kinesis 2
10596583 21.69 0.0309273 Dock3 dedicator of cyto-kinesis 3
10395466 22.13 0.000965 Dock4 dedicator of cytokinesis 4
10462140 22.31 0.0004627 Dock8 dedicator of cytokinesis 8
10422436 21.97 0.0022849 Dock9 dedicator of cytokinesis 9
10421877 21.66 0.0311587 Diap3 diaphanous homolog 3 (Drosophila)
10497520 21.76 0.0025788 Ect2 ect2 oncogene
10403842 25.05 0.0001519 Elmo1 engulfment and cell motility 1, ced-12 homolog (C.
elegans)
10482795 212.02 5.84E-05 Ermn ermin, ERM-like protein
10527158 22.20 0.00327 Fscn1 fascin homolog 1, actin bundling protein (Strongylocentro-
tus purpuratus)
10474619 21.55 0.033766 Fmn1 formin 1
10381708 21.68 0.0131622 Fmnl1 formin-like 1
10472097 22.01 0.0009141 Fmnl2 formin-like 2
10432439 22.00 0.0239411 Fmnl3 formin-like 3
10397645 24.66 0.0012817 Gpr65 G-protein coupled receptor 65
10377215 21.88 0.011931 Gas7 growth arrest specific 7
10439514 22.81 0.0010624 Gap43 growth associated protein 43
10385248 22.37 0.0041239 Hmmr hyaluronan mediated motility receptor (RHAMM)
10443980 22.06 0.0030496 Myo1f myosin IF
10555118 22.35 0.0005103 Pak1 p21 protein (Cdc42/Rac)-activated kinase 1
10488033 22.63 0.0021231 Pak7 p21 protein (Cdc42/Rac)-activated kinase 7
10425852 21.92 0.0085373 Parvb parvin, beta
10425866 22.03 0.0015526 Parvg parvin, gamma
10507273 25.02 0.0025367 Pik3r3 phosphatidylinositol 3 kinase, regulatory subunit, polypep-
tide 3 (p55)
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TABLE 2: Continued
ID Fold
change
adj.P.Val Gene
symbol
Gene description
10344837 22.89 0.0020804 Prex2 phosphatidylinositol-3,4,5-trisphosphate-dependent Rac
exchange factor 2
10522503 22.56 0.001122 Pdgfra platelet derived growth factor receptor, alpha polypeptide
10384458 21.85 0.0201384 Plek pleckstrin
10558134 25.05 6.82E-05 Plekha1 pleckstrin homology domain containing, family A (phos-
phoinositide binding specific) member 1
10396800 24.60 0.0001686 Plekhh1 pleckstrin homology domain containing, family H (with
MyTH4 domain) member 1
10557177 22.76 0.0015186 Prkcb protein kinase C, beta
10469255 22.89 0.0002663 Prkcq protein kinase C, theta
10502419 21.62 0.00912 Rap1gds1 RAP1, GTP-GDP dissociation stimulator 1
10399360 21.83 0.009593 Rhob ras homolog gene family, member B
10566132 21.63 0.007394 Rhog ras homolog gene family, member G
10417065 21.62 0.0109287 Rap2a RAS related protein 2a
10563641 21.85 0.0093145 Rap1a RAS-related protein-1a
10381416 22.24 0.0128636 Rnd2 Rho family GTPase 2
10546010 22.04 0.0167092 Arhgap25 Rho GTPase activating protein 25
10351603 21.82 0.0172861 Arhgap30 Rho GTPase activating protein 30
10548892 21.76 0.0253338 Arhgdib Rho, GDP dissociation inhibitor (GDI) beta
10493789 21.67 0.0023357 S100a13 S100 calcium binding protein A13
10519747 21.64 0.0285887 Sema3e sema domain, immunoglobulin domain (Ig), short basic
domain, secreted, (semaphorin) 3E
10409240 22.57 0.0016994 Sema4d sema domain, immunoglobulin domain (Ig), transmem-
brane domain (TM) and short cytoplasmic domain, (sema-
phorin) 4D
10458843 22.29 0.0032633 Sema6a sema domain, transmembrane domain (TM), and cytoplas-
mic domain, (semaphorin) 6A
10602840 22.17 0.0063362 Sh3kbp1 SH3-domain kinase binding protein 1
10378833 23.07 0.0005775 Ssh2 slingshot homolog 2 (Drosophila)
10390430 22.00 0.0073853 Srcin1 SRC kinase signaling inhibitor 1
10459084 21.55 0.0168555 Synpo synaptopodin
10507347 21.80 0.031309 Tesk2 testis-specific kinase 2
10504817 22.28 0.0027627 Tgfbr1 transforming growth factor, beta receptor I
10355806 21.57 0.0437603 Tuba4a tubulin, alpha 4A
10408613 21.74 0.0023515 Tubb2b tubulin, beta 2B class IIB
10576332 27.73 0.0008025 Tubb3 tubulin, beta 3 class III
10452295 213.79 0.0007598 Tubb4a tubulin, beta 4A class IVA
10450605 21.55 0.0220591 Tubb5 tubulin, beta 5 class I
10446253 22.40 0.0030188 Vav1 vav 1 oncogene
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TABLE 2: Continued
ID Fold
change
adj.P.Val Gene
symbol
Gene description
10362717 22.82 0.00025 Wasf1 WAS protein family, member 1
10483698 22.16 0.0004667 Wipf1 WAS/WASL interacting protein family, member 1
10603440 21.74 0.0052575 Was Wiskott-Aldrich syndrome homolog (human)
Response to hypoxia and oxidative stress
10480734 23.25 0.0483629 Ptgds prostaglandin D2 synthase (brain)
10501199 22.76 0.003673 Gstm7 Glutathione S-transferase, mu 7
10385583 22.57 0.0015118 Ltc4s leukotriene C4 synthase
10545101 22.34 0.0021426 Hpgds hematopoietic prostaglandin D synthase
10515090 22.24 0.0050272 Cdkn2c cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
10376201 22.06 0.0135463 Gpx3 glutathione peroxidase 3
10384725 22.01 0.0231887 Rel reticuloendotheliosis oncogene
10363000 1.53 0.0108136 Gpx4 glutathione peroxidase 4
10443463 1.53 0.0265879 Cdkn1a cyclin-dependent kinase inhibitor 1A (P21)
10545045 1.56 0.0157857 Fam13a family with sequence similarity 13, member A
10467921 1.57 0.0166023 Chuk conserved helix-loop-helix ubiquitous kinase
10492428 1.58 0.0049631 Tiparp TCDD-inducible poly(ADP-ribose) polymerase
10515007 1.65 0.0284022 Gpx7 glutathione peroxidase 7
10595148 1.67 0.0128636 Gsta2 glutathione S-transferase, alpha 2 (Yc2)
10520862 1.68 0.006082 Fosl2 fos-like antigen 2
10571274 1.69 0.0302501 Gsr glutathione reductase
10485466 1.69 0.0040562 Cat catalase
10345065 1.74 0.0262016 Gsta3 glutathione S-transferase, alpha 3
10382243 1.79 0.006033 Gna13 guanine nucleotide binding protein, alpha 13
10370013 1.85 0.003188 Gstt2 glutathione S-transferase, theta 2
10488879 1.92 0.0016807 Gss glutathione synthetase
10419198 1.94 0.0048617 Ero1l ERO1-like (S. cerevisiae)
10547641 1.97 0.0042575 Slc2a3 solute carrier family 2 (facilitated glucose transporter), mem-
ber 3
10540472 2.00 0.0236792 Bhlhe40 basic helix-loop-helix family, member e40
10365260 2.08 0.0110414 Txnrd1 thioredoxin reductase 1
10501222 2.17 0.0098926 Gstm2 glutathione S-transferase, mu 2
10495763 2.22 0.0010623 Gclm glutamate-cysteine ligase, modifier subunit
10478890 2.34 0.0018744 Cebpb CCAAT/enhancer binding protein (C/EBP), beta
10460585 2.38 0.0050272 Fosl1 fos-like antigen 1
10501235 2.41 0.0170212 Gstm4 glutathione S-transferase, mu 4
10545658 2.45 0.0031974 Wdr54 WD repeat domain 54
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layer. These findings could implicate that in vivo lesioning of
the brain parenchyma and lateral ventricle wall induces PV-
expression not only in ependymal cells but also in other glial
cell types adjacent to the injury that might participate in the
formation of a glial scar. In addition, the fact that 6 weeks
post-injury PV-expression was still present in the ependymal
layer adjacent to the lesion implicates that the upregulation of
PV in ependymal cells upon injury lasts for a relatively long
time after the injury. This suggests that the tissue repair and
healing, resp. reuniting of the ependymal and parenchymal
wound rims is a fairly long process and requires a long-
lasting remodeling of the cells taking part in this procedure.
To ascertain whether the injury-induced increase in the
number of PV-expressing cells in the wild-type animals and of
the EGFP-expressing ones in the PV-KO/EGFP mice was a
result of proliferation, the in vivo BrdU-based approach was
instrumented. Mice received cumulative BrdU-injections (24 h
and 3 h prior to sacrifice), and the number of BrdU1 cells
were counted in coronal brain sections. Although numerous
BrdU-positive nuclei were observed close to the lesion and to
the ependymal layer, most of the proliferating cells were
encountered at some distance from the latter. We thus con-
clude that the immunoreactivity for PV that was observed in
the ependymal cells of the lateral ventricle wall and in those
surrounding the lesion resulted from the de novo expression of
the CaBP rather than from cell proliferation. The numerical
density of BrdU-positive nuclei around the lesion was lower in
the PV-KO/EGFP mice than in their wild-type counterparts
(55.5 cells 6 13.5 in WT vs. 33.4 6 11.6 in PV-KO/EGFP
in the VZ lesion, P 5 0.00013, Student’s t test; 82.6 cells 6
17.3 in WT vs. 50.1 cells 616.0 in PV-KO/EGFP in the
lesion and surroundings, P 5 0.00002), whereas that of pro-
genitor cells in the SVZ was similar in each strain (43.0 cells
6 6.8 in WT vs. 43.0 cells 6 5.8 in PV-KO, P 5 0.98) (Fig.
8K). These findings indicate impairment of the PV-KO/EGFP
mice in the post-injury cell proliferation that is needed for the
formation of a glial scar. Taking together these results and our
previous observations that the remodeling and maintenance of
ependymal clusters is impaired in the OHSCs of the PV-KO
mice, we conclude that parvalbumin contributes to the reor-
ganization of ependymal cells following injury.
PV-deficient Mice Exhibit More Severe Ventricular
Enlargement Following Low-dose Intraventricular
Neuraminidase Injection
Based on the observation of others (Luo et al., 2008; Shook
et al., 2013) indicating that intraventricular injection of neur-
aminidase leads to ependymal denudation and ventriculome-
galy, we wondered whether PV also plays a role in non-
traumatic experimental paradigm. Neuraminidase cleaves gly-
cosidic linkages of adherens junctions from the surface of
ependymal cells, thereby resulting in denudation of the epen-
dymal layer (Grondona et al., 1996). High concentration of
neuraminidase (1 mL of 100–500 ng mL21) was shown to
induce the denudation of large ependymal areas and to result
in extensive ependymal loss and gliosis along the ventricles
TABLE 2: Continued
ID Fold
change
adj.P.Val Gene
symbol
Gene description
10480035 2.59 0.0015395 Pfkfb3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
10563338 2.91 0.0089732 Ppp1r15a protein phosphatase 1, regulatory (inhibitor) subunit 15A
10572897 3.17 0.0015395 Hmox1 heme oxygenase (decycling) 1
10451198 3.48 0.0005288 Vegfa vascular endothelial growth factor A
10556297 3.55 0.0097619 Adm adrenomedullin
10545130 3.82 0.0003107 Gadd45a growth arrest and DNA-damage-inducible 45 alpha
10458894 5.91 0.0115852 Lox lysyl oxidase
10568369 6.02 0.0001009 Cox6a2 cytochrome c oxidase, subunit VI a, polypeptide 2
10567995 8.32 0.0001009 Nupr1 nuclear protein 1
10450038 8.60 0.0001798 Angptl4 angiopoietin-like 4
A list of genes that were down-, respectively up-regulated in PV-KO ependymal-cell extracts of DIV21-OHSCs as compared to their wild-
type counterparts, as resulted in a whole-transcriptome analysis. Headers include the Affymetrix gene ID, the fold-change value (negative val-
ues meaning down-regulation in the PV-KO as compared to the wild-type, positive fold change values up-regulation, respectively), adjusted
P value, the gene symbol and gene description.
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(Luo et al., 2008), whereas mild denudation by lower dose of
neuraminidase (1 mL of 10 ng mL21 or 10–50 mU mL21) is
comparable to the situation found in aged murine and
human brain (Shook et al., 2013), with moderate ventriculo-
megaly and ventricular gliosis. Very low dose of neuramini-
dase (1 mL of 1 ng mL21) was shown to cause no visible
ependymal loss (Luo et al., 2008). The degree of ventriculo-
megaly and ventricular gliosis following denudation therefore
correspond to the degree of ependymal cell loss. 1 mL neur-
aminidase of 15, 1.5, and 0.15 mUlL21 concentration was
injected into the lateral ventricles of young adult wild-type
(C57BL/6) and PV-KO mice to mimic ependymal denudation,
whereas sham animals received 1 ml sterile saline solution. Ani-
mals were perfused 4 days after a single intraventricular injec-
tion. We performed S100b-, GFAP-, and PV-immunostainings
to reveal the state of the ependymal layer and the degree of
potential ventricular gliosis. We found no increase in GFAP
staining around the ventricles in neuraminidase injected mice
compared with sham animals (data not shown), which is prob-
ably due to the short time allowed after the injection. We
observed ependymal cell loss that was in accordance to previous
findings (Luo et al., 2008). There were no significant differen-
ces in the intensities of S100b- and GFAP-staining in and
around the ependymal layer when we compared PV-KO and
wild-type animals of the same treatment group. We also meas-
ured the size of the ventricles to estimate the degree of ependy-
mal dysfunction caused by the loss of intact ependymal lining
(Fig. 8L,M). We found that the highest dose of neuraminidase
injection (15 mU) caused a similar ventricular enlargement in
both wild-type and PV-KO mice (Fig. 8L–N). However, lower
doses of neuraminidase (1.5 and 0.15 mU) caused a signifi-
cantly more severe ventriculomegaly in PV-KO mice than did
in their wild-type counterparts (Fig. 8L–N). Together, these
findings show that low doses of neuraminidase which were
described to cause subminimal damage to the ependymal layer,
in the absence of PV lead to serious consequences. However, by
PV-immunohistochemistry we failed to detect an up-regulation
of this CaBP in the ependymal layer following varying doses of
neuraminidase compared with the ependyma of sham-injected
animals (Fig. 8O). On the basis of these findings, we conclude
that in vivo enzymatic dissociation of ependymal cells by neuro-
aminidase does not trigger parvalbumin-expression.
FIGURE 8: Unilateral in vivo stereotactic injury of the hippocampus and lateral ventricle in adult wild-type and PV-KO/EGFP mice induces
PV-, resp. EGFP-expression adjacent to the lesion, whereas neuraminidase-triggered denudation does not induce it. (A) Schematic image
illustrates the lesion site from a dorsal view of the mouse brain. The stereotactic coordinates of the lesion were chosen to injure the lat-
eral ventricle wall at the level of the ventricular zone (VZ) of the hippocampus in a 1-mm-long parasagittal section from Bregma 21.0
mm to 22.0 mm. Seven days and 6 weeks post-injury mice were perfused and brains were cut at 30-lm-thick coronal sections. (B) PV
was revealed immunohistochemically and visualized with a digital slide scanner. The location of the stab lesion is indicated by a red line.
(C) Confocal z-stack projection image shows that on the injured side (inj.), the ependymal layer adjacent to the lesion shows PV-
immunoreactivity. (D) The ependymal layer of the non-injured side (non-inj.) is immunonegative for PV (confocal z-stack projection). (E–
E’) Confocal z-stack projections of 1-week-post-injury coronal sections of the injured and non-injured side reveal PV-immunoreactivity
(white arrows) in the ependymal layer around the lesion, whereas the non-injured ependymal layer manifests no or minimal PV-
immunostaining. Ependymal layer is marked by S100b, dashed line indicates the location of stab lesion. Inset shows PV-immunopositive
ependymal cells close to the stab lesion at high magnification. (F–F’) Confocal z-stack projections of 6-weeks-post-injury coronal sections
reveal PV-immunoreactivity in the ependymal layer (white arrows) in the injured side, whereas the non-injured ependymal layer remains
PV-immunonegative. Inset shows PV-positive ependymal cells in the ependymal layer (labeled by S100b) at high magnification. Single
PV1 cells can be found in the brain parenchyma at the site of the lesion just above the ependymal layer. (G–G”’) A rostrocaudal series
of 1-week-post-injury coronal sections visualized by confocal laser microscopy at the rostral level of the injury in wild-type (C57BL/6)
mice immunostained for BrdU and PV reveals upregulation of PV in ependymal cells adjacent to the lesion and in a subset of cells
around the injury (white arrows). Dashed line indicates the position of the lesion. The stab lesion (white star) seems partly repaired/
closed by a mass of numerous cells, most of which are PV-positive. The boxed region is shown with corresponding GFAP staining in (I).
(H–H”’.) One week following injury, PV-KO/EGFP ependymal cells acquire strong EGFP-expression adjacent to the lesion (white arrows),
as shown by confocal laser micrographs of a rostrocaudal series of coronal sections at the rostral level of the injury immunostained for
BrdU and EGFP. There is no sign of reunion of the disrupted ependymal wound rims and the lesion (white star) is unclosed. Boxed
region is shown with corresponding GFAP staining in (J). (I) GFAP immunostaining was performed to reveal reactive astrocytes around
the lesion. Astrocytes are present in the wild-type scar and around the ependymal layer, the inset shows at higher magnification that
some cells are co-labeled for GFAP and PV. (J) In the PV-KO-EGFP wound, numerous GFAP1 cells can be found around the ependymal
lesion, but there is no visible glial scar tissue. (K) The number of BrdU-positive cell nuclei was counted per 0.072 mm3 in 13 consecutive
coronal sections at the level of the injury in three regions: in the SVZ, in the lesion zone, and in the lesion with the surrounding paren-
chyma. Visibly, more dividing cells are present around the lesion in wild-type than in PV-KO-EGFP (P calculated by Student’s t test),
whereas the number of dividing cell nuclei remains similar in the SVZ further away from the lesion site. (L and M) Larger lateral ventricles
develop 4 days after varying doses of neuraminidase injection in both wild-type and PV-KO mice compared with saline-injected (sham)
animals. (N) The grade of enlargement seems similar after the injection of 15 mU neuraminidase; however, lower doses of the enzyme
(0.15 and 1.5 mU) resulted in a more explicit ventricular enlargement in PV-KO mice than in their wild-type counterparts. (O) The mean
fluorescent intensity/pixel of PV-immunostaining around the lateral ventricle in sham- and neuraminidase-injected wild-type mice is simi-
lar in all animals. Visibly, neuraminidase injection did not result in the up-regulation of the PV-immunostaining. Error bars show SEM.
(LV: lateral ventricle; **P < 0.005; ***P < 0.0005).
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Discussion
Manipulations that disrupt the integrity of the ependymal
layer, such as the preparation of OHSCs for in vitro mainte-
nance or the infliction of a stab-wound to the ventricular wall
in vivo, induce the rapid de novo expression of the EF-hand
calcium-binding protein parvalbumin in ependymal cells.
Scratches inflicted to ependymal-cell clusters in OHSCs result
in PV-up-regulation, increased ependymal-cell motility and
adhesion, followed by considerably better scratch repair ability
in wild-type compared with PV-KO mice. Blockage of the
inflammatory regulator transcription factor NF-RB inhibits
the synthesis of PV in ependymal cells, whilst exposure to
antioxidants diminishes it. Our findings suggest that injury
and injury-related repair mechanisms induce, either directly
or indirectly, the de novo expression of PV in ependymal cells,
increasing their motility and adhesion, and promoting re-
epithelialization of the scratch and of the wound.
The response of the central nervous system (CNS) to
injury is of a complex nature and involves the participation
of numerous soluble factors and cell types. Initially, the
blood-brain barrier is violated, as a consequence of which leu-
kocytes, macrophages and lymphocytes invade the immuno-
privileged compartment (Kawano et al., 2012). These cells
secrete cytokines and chemokines, which trigger the resident
populations of microglia, astrocytes, and oligodendrocyte pre-
cursors to lay down a glial scar around the lesion (Kawano
et al., 2012).
Only a few studies have addressed the impact on epen-
dymal cells of traumatic brain injury that directly compro-
mises the integrity of the eponymous layer. Post-stroke
ependymal cells acquire reactive-astrocyte-like phenotype,
express de novo GFAP and extend long cytoplasmic processes
(Young et al., 2013). Upon injury, ependymal cells also
exhibit a pronounced fate plasticity (Carlen et al., 2009;
Nomura et al., 2010). Nevertheless, ependymal cells, unlike
other epithelial layers, are considered non-regenerative as they
do not divide in the adult brain (Bruni, 1998; Luo et al.,
2008; Spassky et al., 2005). Intraventricular injection of neur-
aminidase results in ependymal denudation, ventricular gliosis
and irreversible ependymal loss followed by ventriculomegaly
(Luo et al., 2008).
Here, we introduced an experimental model that com-
bined traumatic parenchymal brain injury with mechanical
disruption of the ependymal layer. The de novo expression of
PV in ependymal cells was observed to facilitate the reclosure
of the lesion in vivo and the scratch-wound closure and adhe-
sion of ependymal cells in vitro. Consequently, we suspected
that the de novo expression of PV in ependymal cells might
play a role in injury-induced processes that favor tissue
remodeling, wound closure and eventually scar formation. A
comparative whole-transcriptome analysis of the reactive
ependymal-niche extracts of wild-type and PV-KO OHSCs
revealed that in the latter, the expression levels of genes that
are implicated in cytoskeletal remodeling, cell motility and
cell adhesion were decreased, whereas those that are impli-
cated in hypoxic damage were elevated. Hence, the absence of
PV might reduce mobility and adhesion and enhance the vul-
nerability of ependymal cells to injury-induced hypoxic dam-
age and compromise their capacity for tissue remodeling and
wound closure.
The stem-cell attributes of ependymal cells are still a
subject of debate (Chojnacki et al., 2009). It is believed that
lateral ventricle wall ependymal cells lack self-renewal poten-
tial, whereas spinal cord ependymal cells possess certain stem
cell properties; however, in vivo they generate progeny only
upon injury and not under physiological conditions (Meletis
et al., 2008; Pfenninger et al., 2011). In our own experiments
with OHSCs, co-localization of the PV-expressing ependymal
cells with the proliferation marker Ki67 was hardly ever
observed. Similarly in vivo, the infliction of a stab-wound did
not result in the labeling of PV-expressing ependymal cells
with BrdU. These findings indicate that the subpopulation of
injury-reactive, PV-expressing ependymal cells is post-mitotic.
Cells of the ependymal layer interdigitate via plasma-
lemmal adherens junctions (Del Bigio, 2010), and ankyrin-3
in the lateral membrane (Paez-Gonzalez et al., 2011), which
may play a role in the “sealing of the epithelium.” In the
OHSCs of PV-KO mice, the junctions and the interdigita-
tions of the ependymal cells were loosened. This phenom-
enon correlated with the observed down-regulation of a set of
cellular junction-related genes. These included not only the
ankyrin-3 encoding gene Ank3, but also adherens-junction-
specific genes, such as cadherins and protocadherins and the
tight-junction-specific ZO-1 protein-encoding gene Tjp1. We
also observed striking differences in the morphology of the
injury-reactive ependymal cells following in vivo lesioning:
the ependymal cells of the PV-KO mice remained in situ and
did not display a radial phenotype, whereas PV-expressing
ependymal cells of the wild-type mice protruded long cyto-
plasmic processes (Fig. 8I,J).
Because the main described function of PV is calcium-
buffering (Schwaller 2010), the differences in the phenotypic
and the migrating properties of the ependymal cells between
wild-type and PV-KO strains of mice suggest that their motil-
ity and cytoskeletal remodeling are regulated by an as yet
unidentified calcium-dependent process. This postulate
accords with the finding that several of the genes that are
implicated in the control of Cdc42/Rac1/Rho-signaling path-
way, which regulates the motility of cells and changes in their
shape (Bokoch, 2003; Pollard and Borisy, 2003), were down-
regulated in the PV-KO mice (e.g., Pak1, Vav1, Wasf1,
Arpc1a, Arpc1b, and Rap1a). In contrast to S100b, which acts
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as a Ca21-sensor and has a relatively low affinity for Ca21
under physiologic ionic conditions (Donato, 1999), PV is
classified as a slow-onset Ca21-buffer, which has a high bind-
ing affinity for the intracellular cation (Schwaller, 2010). By
the sequestration of calcium within subcellular compartments,
CaBPs facilitate the generation of [Ca21]i gradients (Schwal-
ler, 2010). The maintenance of these polarized gradients in
[Ca21]i is vital for many biological functions (Wahl et al.,
1992), including cell motility. The buffering capacity of PV
might also facilitate the “quenching” of excessive amounts of
calcium that flood cells during injury, mechanical stress, and
the release of cytokines.
Our observation that the up-regulation of parvalbumin
in ependymal cells contributes to their motility was antici-
pated by unrelated studies using other systems. In the fast-
twitch muscles of mice, the transient binding of PV to intra-
cellular calcium facilitates the rapid relaxation of the muscle
fibers. As a consequence, in the muscles of PV-KO mice, the
relaxation-time is prolonged (Schwaller et al., 1999), whereas
in PV-transgenic muscles it is shortened (Muntener et al.,
1995). A promoting effect of PV on cell motility has been
observed also in cultured WiDr-cells that were transfected
with PV-cDNA (Andressen et al., 1995). These cells display a
higher capacity to undergo amoeboid-like movements than
do their wild-type counterparts.
In neurons, PV plays a role not in their motility but in
the regulation of their electrophysiology (Caillard et al., 2000;
Collin et al., 2005; Muller et al., 2007; Vreugdenhil et al.,
2003). Under experimental and pathologic conditions, the
concentration of PV in neurons can be altered (Levitt et al.,
2004). For example, the administration of ketamine provokes a
loss of PV-immunoreactivity from GABA-ergic interneurons
and a decrease in their inhibitory potency by increasing the
level of the pro-inflammatory cytokine IL-6 in the brain, which
activates the superoxide-producing enzyme NADPH oxidase
(Behrens and Sejnowski, 2009; Powell et al., 2012). In murine
models, treatment regimes that restore the redox balance, such
as the administration of the antioxidant N-acetylcysteine, help
to correct some of these deficits (Cabungcal et al., 2006; Kulak
et al., 2013). As our own study has shown, ependymal cells
react to the same inflammatory cytokines (e.g., IL-6) in a man-
ner that differs basically from that of neurons, namely, by the
de novo synthesis of PV. Cell-type-specific differences in the
regulation of the Pvalb-promoter have not been reported, but
have been documented for other CaBPs. In nerve cells, the
calretinin-promoter contains a specific AP2-like element that
assures a neuron-specific pattern of gene-expression (Billing-
Marczak et al., 2002). In colon cancer cells, butyrate down-
regulates the expression of calretinin (Haner et al., 2010),
whereas in mesothelioma cells, none of these mechanisms
influence its expression (Haner et al., 2010).
A role in protecting cells against deleterious increases in
[Ca21]i (Schwaller et al., 2002) could underlie the de novo
expression of PV in ependymal cells. In various experimental
in vivo models, PV protected vulnerable neurons (Beers et al.,
2001; Friedman and Segal, 2010; Nitsch et al., 1989; Van
Den Bosch et al., 2002). In other instances, PV-
immunoreactivity did not prevent neuronal cell death (Dijk
and Kamphuis, 2004; Maetzler et al., 2004). Because PV
constitutes only one of the many components of the calcium
homeostasome (Berridge et al., 2003; Schwaller, 2012), its
protective role may be masked in experimental models in vivo
by the complexity of the physiological situation. Calretinin,
another member of the same EF-hand family of CaBPs, has
been shown to have a convincing protective effect on cells.
This CaBP is expressed in colonic cancer cells, and in reactive
as well as in neoplastic mesothelial cells. In both cell types,
calretinin promotes growth and survival, and its down-
regulation by the administration of antisense oligodeoxynu-
cleotides (Gander et al., 1996), or by treatment with
lentiviral-mediated shRNA (Blum and Schwaller, 2013),
respectively, leads to apoptotic cell death.
We have here shown that the PV-positive ependymal
cells of wild-type mice adapt better to the altered conditions
following mechanical injury than do the counterparts of PV-
KO ones, indicating that this CaBP benefits the ependymal
cells.
By showing that the calcium-binding protein parvalbu-
min plays an unsuspected role in the response of ependymal
cells, the findings of this study furnish a basis for improving
our understanding of the cascade of events that is triggered
by traumatic brain injury.
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